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II. Structure of the thesis  
This thesis consists of introduction (Chapter 1), methods (Chapter 2), results 
(Chapter 3) and summarizing discussion (Chapter 4). Chapter 2 contains a 
manuscript on methods to generate neural cultures as well as use of these 
cultures for metabolic studies that has been submitted for an invited book 
chapter in ‘Neuromethods: Brain Energy Metabolism’. Chapter 3 comprises of 
four parts with three publications (3.1, 3.2 and 3.3) and a submitted 
manuscript (3.4). 
The publications in chapters 3.1 to 3.3 are included as portable document 
formats. The submitted manuscripts (Chapters 2 and 3.4) have been formatted 
to maintain uniformity in the layout of this thesis, without altering the content. 
For ease of reading the manuscripts, tables and figures with their legends have 
been placed in the text body (Chapter 2) or before the discussion section 
(Chapter 3.4). The figures and tables in chapters 1 and 4 are numbered with a 
different style than that in manuscripts/publications. At the end of each 
chapter the references are listed pertaining to the citations in that chapter. For 
publications and manuscripts, the experimental contributions of all authors are 
listed on the first page of each chapter. 
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III. Summary 
Formaldehyde is an environmental pollutant that is also generated in the body 
during normal metabolic processes. Interestingly, several pathological 
conditions are associated with an increase in formaldehyde-generating enzymes 
in the body. The level of formaldehyde in the brain is elevated with increasing 
age and in neurodegenerative conditions which may contribute to lowered 
cognitive functions. Although the neurotoxic potential of formaldehyde is well 
established, the molecular mechanisms involved remain, to a great extent, 
obscure. Also, the ability of the different types of brain cells to metabolize 
formaldehyde has not been reported so far. 
This thesis investigated the capacity of cultured brain cells to metabolize 
formaldehyde and studied the effects of a formaldehyde exposure on the glucose 
and the glutathione metabolism by using primary cultures of cerebellar granule 
neurons or astrocytes as well as the oligodendroglial cell-line OLN-93 as model 
systems.  These cultured cells were remarkably resistant towards acute toxicity 
of formaldehyde and expressed the mRNAs for enzymes that are known to be 
involved in formaldehyde generation and disposal, suggesting that brain cells 
are able to metabolize this aldehyde. Furthermore, all three types of cultures 
cleared exogenously applied formaldehyde with almost identical rates, but 
differed in the extent of the formation of the formaldehyde oxidation product, 
formate. 
Since formate is a known inhibitor of the cytochrome c oxidase of the 
mitochondrial respiratory chain and since the metabolism of formaldehyde 
involves the important antioxidant glutathione, the effect of an exposure of 
cultured brain cells to formaldehyde on their glucose and glutathione 
metabolism was also investigated. Formaldehyde application accelerated the 
export of glycolysis-derived lactate and induced a rapid multidrug-resistance 
protein 1-mediated export of glutathione from cultured brain cells. These 
formaldehyde-induced alterations in metabolic pathways of brain cells may 
contribute to the known impairments in memory and learning that have been 
reported for neurodegenerative conditions and for formaldehyde-exposed 
animals.   
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IV. Zusammenfassung 
Formaldehyd ist ein Umwelttoxin, das jedoch auch als normales 
Stoffwechselintermediat im Körper gebildet wird. Interessanterweise ist der 
Formaldehydgehalt in Gehirn bei zunehmendem Alter und bei 
neurodegenerativen Erkrankungen erhöht, was zu verringerten kognitiven 
Leistungen beitragen könnte. Obwohl das neurotoxische Potential von 
Formaldehyd gut bekannt ist, sind die beteiligten molekularen Mechanismen 
weitgehend unerforscht. Ebenso ist das Potential der verschiedenen Typen von 
Gehirnzellen zur Metabolisierung von Formaldehyd bis dato nicht beschrieben. 
Die vorliegende Dissertation untersuchte die Fähigkeit von Gehirnzellen in 
Kultur zur Metabolisierung von Formaldehyd sowie Wirkung einer 
Formaldehydexposition auf den Glukose- und Glutathionmetabolismus  an 
Primärkulturen von cerebellaren Körnerzellen oder Astrozyten sowie an der 
oligodendroglialen Zelllinie OLN-93 als Modellsystemen.  Diese Zellkulturen 
waren außerordentlich widerstandsfähig gegenüber akuter Formaldehyd-
toxizität und exprimierten die mRNAs für Enzyme, die an der Bildung und 
Beseitigung von Formaldehyd beteiligt sind. Dies weist darauf hin, dass diese 
Gehirnzellen Formaldehyd metabolisieren können. Weiterhin beseitigten die 
drei untersuchen Zelltypen exogen appliziertes Formaldehyd mit nahezu 
identischer Geschwindigkeit, unterschieden sich aber im Ausmaß der Bildung 
des Formaldehyd-Oxidationsproduktes Formiat.  
Da Formiat ein Hemmstoff der Cytochrom-c-Oxidase der mitochondrialen 
Atmungskette ist, und bei der Formaldehydoxidation das wichtige Antioxidans 
Glutathion beteiligt ist, wurden die Effekte von Formaldehyd auf den Glukose- 
und Glutathionstoffwechsel in Gehirnzellkulturen untersucht. Die Gabe von 
Formaldehyd steigerte den Export des Glycolyseproduktes Laktat und führte zu 
einem schnellen, Multidrug resistance protein-1-vermittelten Export von 
Glutathion aus Gehirnzellen. Die Formaldehyd-induzierten Veränderungen in 
diesen wichtigen Stoffwechselwegen von Gehirnzellen könnten zu den 
Beeinträchtigungen von Gedächtnis und Lernen beitragen, welche für 
neurodegenerative Erkrankungen sowie eine Formaldehydexposition von Tieren 
beschrieben wurden.  
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V. Abbreviations 
?C degree  
% percent  
? molar extinction co-efficient 
µ micro 
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2VP 2-vinylpyridine  
Aal acetaldehyde 
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ATP adenosine triphosphate 
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c concentration 
CAS Chemical Abstracts Service 
cDNA complementary deoxyribonucleic acid  
CGNC(s) cerebellar granule neuron culture(s) 
CNP 2’,3’-cyclic nucleotide 3’-phosphodiesterase 
CNS central nervous system 
d path length 
DAPI 4’-6-diamidino-2-phenylindole dihydrochloride  
DTNB 5,5’-dithio-bis(2-nitrobenzoic acid)  
DMEM Dulbecco’s modified Eagle’s medium  
DNA deoxyribonucleic acid  
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Ed(s). editor(s) 
EDTA ethylenediamine tetraacetate  
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Fal formaldehyde  
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Fig. figure(s) 
g acceleration of gravity 
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GDNF glial cell line-derived neurotrophic factor 
GFAP glial fibrillary acidic protein 
G6P glucose-6-phosphate 
G6PDH glucose-6-phosphate dehydrogenase  
GR glutathione reductase 
GPT glutamate pyruvate transaminase 
GSH glutathione 
GSSG glutathione disulfide 
GSx total glutathione 
?-GT ?-glutamyl transpeptidase  
h hour(s) 
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HEPES 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid  
HK hexokinase 
IARC International Agency for Research on Cancer 
IB incubation buffer 
IL interleukin  
JHDM JmjC domain-containing histone demethylases 
Km Michaelis-Menten constant 
L liter 
LDH lactate dehydrogenase 
LSD lysine-specific demethylase  
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M molar (mol per L) 
MAG myelin-associated glycoprotein 
MAP microtubule-associated protein  
MCT monocarboxylate transporter 
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mEBSS modified Earle’s balanced salt solution 
min minute(s) 
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mRNA messenger ribonucleic acid  
Mrp multidrug resistance protein  
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MTHFD methylene tetrahydrofolate dehydrogenase 
n nano 
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RT room temperature 
RT-PCR(s) reverse transcription polymerase chain reaction(s) 
s second(s) 
sd standard deviation 
SSA sulfosalicylic acid 
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1.1. Formaldehyde 
Formaldehyde, also known as methanal, is the simplest aldehyde and was first 
described in 1855 by a Russian scientist named Alexander Michailowitsch 
Butlerow (Salthammer et al., 2010). The chemical synthesis of formaldehyde by 
methanol dehydration was first achieved in 1867 by a German chemist, August 
Wilhelm von Hofmann (Salthammer et al., 2010). In the years to follow, the 
properties of formaldehyde were extensively studied and this compound was 
one of the earliest to obtain a Chemical Abstracts Service (CAS) registry number 
(50-00-0). Formaldehyde is highly reactive and can undergo hydration or form 
hemiacetals with alcohols, thiohemiacetals with thiols and Schiff bases with 
amines (Vollhardt and Schore, 2005) which makes this aldehyde an important 
compound in industries (Tang et al., 2009). The following section highlights the 
different modes of formaldehyde exposure in humans, its cellular metabolism 
and also implications of increased formaldehyde levels in diseases.  
 
 
Figure 1.1: Industrial use of formaldehyde as a chemical feedstock. 
Modified from Salthammer et al. (2010). 
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1.1.1. Exogenous sources of formaldehyde 
Formaldehyde is commercially synthesized by silver- or ferric molybdate-
catalyzed oxidation of methanol (Kralj, 2010; Qian et al., 2003). In 2006 the 
annual global production of formaldehyde was 32 million tons, with China 
(34%), United States (14%) and Germany (8%) being the highest contributors 
(Tang et al., 2009). Such a high production of formaldehyde can be attributed to 
the vast industrial applications of this compound (Fig. 1.1).  
Owing to the extensive industrial use of formaldehyde, a number of commonly 
used products contain either this compound or formaldehyde-releasing 
substances (de Groot et al., 2009; Sasseville, 2004). Some examples of such 
products are construction materials, agricultural fertilizers, fumigants, paints, 
cosmetics, antiperspirants, polish, cleaning agents and toiletries (de Groot et 
al., 2010; de Groot et al., 2009; Sasseville, 2004). In addition, formaldehyde can 
be produced and released from burning of wood, coal, tobacco, natural gas and 
kerosene (de Groot et al., 2009; Laitinen et al., 2010). Such a broad spectrum of 
products and processes that contain and/or release formaldehyde makes this 
aldehyde a ubiquitous compound. Hence, it is not surprising that formaldehyde 
can also be detected in residential indoor air across the globe (Table 1.1). 
Table 1.1: Some studies reporting the presence of formaldehyde in 
residential indoor air. 
 
Country 
 
References 
 
Canada  
 
Gilbert et al., 2005; Heroux et al., 2010   
Japan Azuma et al., 2007; Ohura et al., 2006;  
Park and Ikeda, 2006; Sakai et al., 2004 
 
China Guo et al., 2009; Li et al., 2008;  
Wang et al., 2007; Zhao et al., 2004 
 
USA Hun et al., 2010; Kinney et al., 2002;  
Offermann et al., 2009 
 
France Clarisse et al., 2003; Marchand et al., 2006; 
Marchand et al., 2008  
 
Germany de Bruin et al., 2008; Ullrich, 2002 
Sweden Sakai et al., 2004; Gustafson et al., 2005;  
Gustafson et al., 2007;  
 
Mexico Baez et al., 2003;  
Serrano-Trespalacios et al., 2004  
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The World Health Organization (WHO) reviewed literature on formaldehyde 
levels in the air and its consequences on health in 2010 to set a short-term (30 
min) guideline for maximal formaldehyde concentration in the air of 0.1 mg/m3 
(WHO, 2010) which corresponds to around 0.08 ppm. Guidelines for 
formaldehyde concentration in indoor air are also set by health authorities in 
different countries. For example, in Germany an indoor air guideline value of 
0.1 ppm was established in 1977 and has remained unchanged even after the 
recent reassessment in 2006 (Salthammer et al., 2010). 
Inhalation and contact with skin are not the only modes of formaldehyde 
exposure in humans. Formaldehyde can also enter the body by consumption of 
coffee, codfish, meat, poultry and maple syrup which naturally contain 
formaldehyde (de Groot et al., 2009; Dhareshwar and Stella, 2008). Moreover, 
the illicit use of Rongalite®, a food preservative synthesized from formaldehyde, 
increases the potential risk of exposure to this aldehyde (Tang et al., 2009). 
Furthermore, aspartame, an artificial sweetener, and some prodrugs also 
release formaldehyde on their metabolism in the body (Dhareshwar and Stella, 
2008; Monte, 2010). 
 
 
1.1.2. Endogenous formaldehyde generation 
A number of metabolic processes in the body generate formaldehyde. Some of 
these important endogenous reactions contributing to formaldehyde production 
are described in this section. 
 
 
1.1.2.1. Methanol oxidation 
Methanol can be produced within the body by hydrolysis of protein 
carboxymethyl esters either non-enzymatically or catalyzed by methylesterases 
(Lee et al., 2008). Additionally, accidental or intentional intake of methanol can 
further expose the body to this alcohol. In the body, methanol oxidation to 
formaldehyde can occur by three different pathways (Fig. 1.2). The first pathway 
involves the cytosolic enzyme alcohol dehydrogenase (ADH) 1 which oxidizes 
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methanol to formaldehyde along with the reduction of NAD+ to NADH 
(Friedenson, 2011; Harris et al., 2003; MacAllister et al., 2011). Alternatively, 
hydrogen peroxide, most likely generated by NADPH-dependent electron 
transfer, contributes to the direct oxidation of methanol by catalase (Fig. 1.2). 
The hydrogen peroxide can also undergo Fenton chemistry to form hydroxyl 
radical which oxidizes methanol, thereby generating formaldehyde (Fig. 1.2). 
Although in all animals the principle site of methanol oxidation is the liver, the 
metabolic pathways involved in this process depend on the species 
(Skrzydlewska, 2003; Sweeting et al., 2011; Tephly, 1991). While humans and 
monkeys oxidize methanol with the aid of ADH1, this step is mediated 
predominantly by catalase in rats and mice (Skrzydlewska, 2003; Sweeting et 
al., 2011; Tephly, 1991).  
 
 
Figure 1.2: Formaldehyde generation by methanol oxidation. 
Methanol can be oxidized to formaldehyde in an enzymatic reaction 
catalyzed by alcohol dehydrogenase (ADH) 1 or catalase and non-
enzymatically by the reaction with hydroxyl radicals. Modified from 
MacAllister et al. (2011). 
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1.1.2.2. Deamination of methylamine  
Semicarbazide-sensitive amine oxidase (SSAO) is a common name for a group of 
copper-containing amine oxidases which are inhibited by semicarbazide and 
most of them contain topa-quinone at their catalytic centre (Jalkanen and 
Salmi, 2001; Yu et al., 2003). The oxidative deamination of primary amines by 
SSAO yields the corresponding aldehyde, ammonia and hydrogen peroxide 
(Jalkanen and Salmi, 2008; O’Sullivan et al., 2004). Thus, when methylamine, 
an endogenous amine (Li et al., 2004; Nunes et al., 2011) is utilized as a 
substrate in SSAO-catalyzed reaction formaldehyde is generated (Fig. 1.3) 
(O’Sullivan et al., 2004; Yu et al., 2003). Vascular adhesion protein (VAP) 1 is 
an enzyme which belongs to SSAO (Jalkanen and Salmi, 2008; Smith and 
Vainio, 2007) and is one of the most extensively studied members of this group. 
SSAO is found in a wide range of organisms from microbes to plants and 
mammals (Brazeau et al., 2004; MacPherson and Murphy, 2007) and plays an 
important role in the detoxification of xenobiotic amines, glucose uptake and 
cell-adhesion in leukocyte trafficking (Jalkanen and Salmi, 2001, 2008; Yu et 
al., 2003). In mammals, SSAO is either membrane-associated or in a soluble 
form circulating in the vascular system (Jalkanen and Salmi, 2001).  
 
 
 
Figure 1.3: Deamination of methylamine generates formaldehyde. 
Semicarbazide-sensitive amine oxidase (SSAO) catalyzes the oxidative 
deamination of methylamine to yield formaldehyde, hydrogen peroxide 
and ammonia. 
 
 
1.1.2.3. Histone demethylation  
Lysine-specific demethylase  (LSD) 1 and JmjC domain-containing histone 
demethylases (JHDM) are enzymes that remove methyl groups from methylated 
lysine residues in histones, thereby altering the chromatin structure and 
playing an important role in regulation of gene expression (Cheng and Zhang, 
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2007; Cloos et al., 2008; Hou and Yu, 2010; Izzo and Schneider, 2010). 
Removal of a methyl group by either LSD1 or JHDM yields formaldehyde as a 
by-product (Fig. 1.4) (Cloos et al., 2008; Hou and Yu, 2010). LSD1 is a flavin-
containing enzyme that selectively demethylates the mono- or dimethylated 
lysine residue in position 4 of histone H3 (Forneris et al., 2009; Hou and Yu, 
2010; Shi, 2007). On the other hand, JHDM require Fe2+ ?????-ketoglutarate as 
cofactors and can remove methyl groups from mono-, di- or trimethylated lysine 
residues (Cheng and Zhang, 2007; Cloos et al., 2008; Hou and Yu, 2010). LSD1 
and JHDM homologues are present in a number of organisms like yeast, plants 
and mammals (Shi, 2007; Sun and Zhou, 2008).  
 
 
Figure 1.4: Formaldehyde generation by demethylation of histones. 
Lysine-specific demethylase (LSD) 1 (A) or JmjC domain-containing 
histone demethylases (JDHM) (B) remove methyl groups from lysine 
residues in histones by two different mechanisms leading to 
formaldehyde generation. R represents either a hydrogen atom or a 
methyl group.  
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1.1.3. Formaldehyde metabolism 
In order to maintain a low physiological level of formaldehyde, cells are 
equipped with the enzymatic machinery necessary for its disposal. Cellular 
metabolism of formaldehyde may yield methanol or formate by the reduction or 
oxidation of formaldehyde, respectively (Fig. 1.5). The reduction of formaldehyde 
to methanol can be catalyzed by ADH1 while formate can be generated by two 
independent pathways mediated by either the cytosolic ADH3 or the 
mitochondrial aldehyde dehydrogenase (ALDH) 2 (Friedenson, 2011; MacAllister 
et al., 2011; Teng et al., 2001).  
 
ADH3, also known as formaldehyde dehydrogenase can oxidize formaldehyde to 
formate in a two-step process that requires glutathione (GSH) (Harris et al., 
2003; MacAllister et al., 2011; Staab et al., 2009; Thompson et al., 2010). In the 
first step, GSH reacts with formaldehyde in an enzyme-independent manner to 
form S-hydroxymethyl GSH that is subsequently used as a substrate by ADH3 
to generate S-formyl GSH, along with the reduction of NAD+ to NADH (Harris et 
al., 2003; MacAllister et al., 2011; Staab et al., 2009; Thompson et al., 2010). 
The formation of S-hydroxymethyl GSH strongly depends on the concentrations 
of formaldehyde and GSH present as this hemithioacetal is in equilibrium with 
the reactants (Ahmed and Anders, 1978). The conjugate S-formyl GSH is 
hydrolyzed by a thiolase to generate formate and GSH (Harris et al., 2003; 
MacAllister et al., 2011; Teng et al., 2001). On the other hand, the reaction 
catalyzed by ALDH2 is GSH-independent wherein NADH is generated along with 
formaldehyde oxidation to formate (MacAllister et al., 2011; Teng et al., 2001). 
The enzymes ADH3 and ALDH2 differ in their Km-values for their respective 
substrates, S-hydroxymethyl GSH and free formaldehyde (Casanova-Schmitz et 
al., 1984; Heck et al., 1990). While ADH3 has a very low Km-value for S-
hydroxymethyl GSH (less than 10 µM), that of ALDH2 for formaldehyde is 
around 0.2-0.5 mM indicating that in the presence of GSH, ADH3 is a more 
important catalyst for formaldehyde oxidation (Casanova-Schmitz et al., 1984; 
Heck et al., 1990).  
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Figure 1.5: Cellular metabolism of formaldehyde. Formaldehyde can 
be oxidized to formate in a reaction catalyzed by cytosolic (cyt) 
glutathione (GSH)-dependent alcohol dehydrogenase (ADH) 3 or by the 
mitochondrial (mito) aldehyde dehydrogenase (ALDH) 2. Reduction of 
formaldehyde by ADH1 can result in generation of methanol. Formate 
can undergo further oxidization to CO2 via a pathway involving 
tetrahydrofolate (THF) where 10-formyl THF is synthesized in the first 
step catalysed by methylene tetrahydrofolate dehydrogenase (MTHFD) 1 
or MTHFD1L in an ATP-dependent reaction. In the next step, 10-formyl 
THF dehydrogenase ALDH1L1 or ALDH1L2 acts on 10-formyl THF to 
produce CO2 and regenerate THF. 
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The formate generated by formaldehyde oxidation can undergo further 
oxidization to carbon dioxide by a pathway dependent on tetrahydrofolate (THF) 
wherein formate is first converted to 10-formyl THF (Fig. 1.5) in an ATP-
dependent reaction (Krupenko et al., 2010; Krupenko, 2009; Skrzydlewska, 
2003). The cytosolic form of the enzyme catalyzing this reaction is called 
methylene tetrahydrofolate dehydrogenase (MTHFD) 1 while the mitochondrial 
form is MTHFD1L (Krupenko, 2009). In the next step the enzyme 10-formyl THF 
dehydrogenase, also known as ALDH1L1 (cytosolic) or its mitochondrial isoform 
ALDH1L2 oxidizes 10-formyl THF to carbon dioxide using NADP+ as a co-factor 
and regenerates THF (Krupenko et al., 2010; Krupenko, 2009; Skrzydlewska, 
2003). Although formate oxidation takes place predominantly by the THF-
dependent pathway, catalase-mediated oxidation can also occur (Cook et al., 
2001; Skrzydlewska, 2003).  
 
 
1.1.4. Formaldehyde in diseases 
The concentration of formaldehyde in the blood has been reported to be around 
0.1 mM (Heck and Casanova, 2004) while that in the brain is about 0.2 mM 
(hippocampus) and 0.4 mM (cortex) (Tong et al., 2012) which can be attributed 
to the balance between formaldehyde-generating and -disposing processes 
described in previous sections. Exposure to exogenous formaldehyde or an 
increase in the activity of formaldehyde-generating enzymes without an increase 
in the capacity to clear this formaldehyde may elevate formaldehyde level in the 
body. Indeed an increased expression/activity of the formaldehyde-generating 
enzymes SSAO, LSD1 and JHDM has been reported in pathology (Table 1.2). 
While elevated levels of SSAO are associated with a broad spectrum of 
pathological conditions, an increase in the expression of histone demethylases, 
LSD1 and JHDM, has been observed in different types of cancer (Table 1.2). In 
line with the increase in formaldehyde-generating enzymes in pathology, 
increased formaldehyde levels have been reported in patients suffering from 
neurodegenerative diseases like Alzheimer’s disease (AD) or multiple sclerosis 
(MS) (Khokhlov et al., 1989 cited in Miao and He, 2012; Tong et al., 2012; Tong 
et al., 2011), in diabetic rats (Tong et al., 2012) and in cancer tissue (Spanel et 
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al., 1999; Tong et al., 2010). Moreover, some human cancer cell lines have also 
been reported to have elevated formaldehyde levels (Kato et al., 2001; Tong et 
al., 2010).  
 
Table 1.2: Elevation of formaldehyde-generating enzymes in disease. 
 
Enzyme 
 
Disease 
 
References 
SSAO/ 
VAP1 
 
Alzheimer’s disease 
 
del Mar Hernandez et al., 2005; 
Ferrer et al., 2002;  
Unzeta et al., 2007 
 
Multiple sclerosis Airas et al., 2006 
 
Heart disease Boomsma et al., 2000;  
Boomsma et al., 2005 
 
Diabetes mellitus 
and diabetic 
complications 
Boomsma et al., 2005;  
Gronvall-Nordquist et al., 2001; 
Karadi et al., 2002;  
Meszaros et al., 1999;  
Obata, 2006   
Chronic liver disease Kurkijarvi et al., 2000 
 
LSD1/ 
JHDM 
 
Sarcoma 
 
Bennani-Baiti et al., 2012; 
Schildhaus et al., 2011 
 
Peripheral nerve 
sheath tumor 
 
 
Schildhaus et al., 2011 
Neuroblastoma 
 
Schulte et al., 2009 
Bladder cancer Hayami et al., 2011;  
Hayami et al., 2010 
 
Breast cancer Lim et al., 2010  
 
Prostate cancer Kahl et al., 2006;  
Xiang et al., 2007 
 
 
1.1.5. Formaldehyde toxicity 
Several in vitro as well as in vivo studies have demonstrated formaldehyde-
mediated cross-linking of proteins, DNA and DNA-proteins (Barker et al., 2005; 
Casanova et al., 1989; Lu et al., 2008a; Metz et al., 2004; Moeller et al., 2011; 
Shaham et al., 2003; Sutherland et al., 2008; Toews et al., 2008) which could 
have deleterious effects on cellular functions. The formation of DNA adducts 
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following formaldehyde exposure are considered to represent important events 
in carcinogenesis and mutagenesis (Lu et al., 2011; Swenberg et al., 2011). 
Based on the extensive literature available on the occurrence of cancer on 
formaldehyde exposure, the International Agency for Research on Cancer (IARC) 
classified this compound as a carcinogenic agent in humans (IARC, 2006). 
Besides its carcinogenic potential, animal studies have revealed that exposure 
to formaldehyde can also cause reproductive and developmental deficits (Duong 
et al., 2011; Köse et al., 2011; Wang et al., 2012). Of particular interest for the 
current work is formaldehyde-induced neurotoxicity (Songur et al., 2010) which 
is described in detail in Section 1.3.3.  
 
 
1.2. Brain cells 
The brain is the most complex organ in the body consisting of more than 100 
billion cells (Azevedo et al., 2009). Brain cells interact extensively with each 
other to ensure proper functioning of this vital organ. This section describes the 
different cells that constitute the brain (Fig. 1.6) and the intimate association 
between them in health and disease. 
 
 
1.2.1. Neurons 
Amongst all the constituent cells of the brain, neurons have been in the spot-
light for the longest time. The first descriptions of nerve cells were done in the 
period from 1833 to 1837 almost simultaneously by two scientists, Christian 
Gottfried Ehrenberg and Johann Evangelista Purkinje (Ehrenberg, 1836; Lopez-
Munoz et al., 2006; Purkinje, 1837). The first microscopic image of a nerve cell 
was published in 1836 by Gabriel Gustav Valentin, a student of Purkinje 
(Lopez-Munoz et al., 2006; Valentin, 1836). However, a major breakthrough in 
the field of neuroscience happened in 1888-89 when the Spanish 
neurobiologist, Santiago Ramón y Cajal, postulated the neuron doctorine (De 
Carlos and Borrell, 2007; Lopez-Munoz et al., 2006; Serrano-Castro and 
Garcia-Torrecillas, 2012). Using cerebellum and retina of birds, Cajal described, 
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in detail, the morphology and arrangement of neurons which is widely accepted 
till date with few modifications (De Carlos and Borrell, 2007; Lopez-Munoz et 
al., 2006; Serrano-Castro and Garcia-Torrecillas, 2012).  
 
 
 
Figure 1.6: Cellular constitution of the brain. The brain is mainly 
composed of neurons and glial cells (astrocytes, oligodendrocytes and 
microglia). Modified from Colombo et al. (2012). 
 
Neurons are characterized by a polarized morphology consisting of a cell-body, 
axon and several highly branched dendrites (Nicholls et al., 2011; Raine, 2007). 
Neurons are excitatory, inhibitory or modulatory in their effects and motor, 
sensory or secretory in their functions (Raine, 2007). These cells communicate 
with each other by means of chemical transmission at synapses (Holz and 
Fisher, 2007). Synaptic transmission involves a series of complex processes like 
depolarization of the presynaptic nerve terminal leading to influx of Ca2+ which 
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in turn triggers exocytosis of small synaptic vesicles that store 
neurotransmitters (Holz and Fisher, 2007; Nicholls et al., 2011). The released 
neurotransmitters interact with receptors on the postsynaptic neuron that are 
either coupled directly with ion channels or act through secondary messengers 
(Holz and Fisher, 2007; Nicholls et al., 2011). The inactivation of 
neurotransmitters occurs either by reuptake at the nerve terminal, degradation 
or uptake and metabolism by glial cells (Holz and Fisher, 2007; Nicholls et al., 
2011). Some examples of neurotransmitters are glutamate and acetylcholine 
that belong to the class of excitatory neurotransmitters (Lester et al., 2010; 
Yang et al., 2011) while ?-amino butyric acid (GABA) and glycine are inhibitory 
neurotransmitters (Bowery and Smart, 2006). 
For efficient functioning of the nervous system, a close co-operation between 
neurons and glial cells is required which is described in detail in the following 
section. Of particular interest in the context of this thesis is the reliance of 
neurons on astrocytic supply of lactate, an energy metabolite, and also GSH 
precursors which is described in Section 1.2.2.1. 
 
 
1.2.2. Glial cells 
Prior to 1856 when Rudolf Virchow coined the term ‘neuroglia’ (glia means glue 
in Greek) to describe the ‘connecting material’ surrounding nerve cells 
(Kettenmann and Verkhratsky, 2008), the brain was thought to comprise 
merely of nerve cells. In 1858, Virchow wrote in a book titled ‘Cellular 
Pathology’- ‘Hitherto, gentlemen, in considering the nervous system, I have only 
spoken of the really nervous parts of it. But if we would study the nervous 
system in its real relations in the body, it is extremely important to have a 
knowledge of that substance also which lies between the proper nervous parts, 
holds them together and gives the whole its form in a greater or less degree’ 
(Kettenmann and Verkhratsky, 2008; Virchow, 1858). Thereafter the concept of 
neuroglia spread in the world and in years to follow astrocytes, oligodendrocytes 
and microglia were described as the different components of the neuroglia (Fig. 
1.6).  
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During evolution, the ratio of glia to neurons in the frontal cortex has increased 
from about 0.3 in rodents to 1.65 in humans (Kettenmann and Verkhratsky, 
2008; Sherwood et al., 2006), suggesting an important role of the former cell 
types in higher organisms. Glial cells constitute more than 90% of all cells in 
the human brain (He and Sun, 2007) and have several specialized functions. 
The functions of different brain glial cell types are described below with special 
emphasis on astrocytes. 
 
 
1.2.2.1. Astrocytes 
Astrocytes, the major type of neuroglia in the brain, were named by Michael von 
Lenhossek (Lenhossek, 1891; Parpura et al., 2012) due to their star-shaped 
appearance. These cells can be divided into two sub-types on the basis of their 
morphology and location in the brain - fibrous astrocytes residing in the white 
matter and protoplasmic astrocytes found in the grey matter (Molofsky et al., 
2012; Sofroniew and Vinters, 2010). Fibrous astrocytes possess elongated fiber-
like processes while protoplasmic astrocytes have fine branched processes in a 
uniform globoid pattern (Molofsky et al., 2012; Sofroniew and Vinters, 2010). 
During evolution, the complexity and size of astrocytes increased 
disproportionately to neurons, which is proposed to reflect the increased 
importance of astrocytic functions in higher organisms (Oberheim et al., 2006). 
In humans, every astrocyte contacts and enwraps about 2 million synapses 
compared to about 0.1 million synapses covered by rodent astrocytes 
(Kettenmann and Verkhratsky, 2008; Oberheim et al., 2006). Astrocytes are 
involved in many important processes including development and maintenance 
of the blood-brain barrier (BBB), guidance of neuronal migration, synaptic 
transmission and neuronal excitability, synaptic generation, regulation of the 
brain microenvironment, in particular regarding neurotransmitter and ionic 
homeostasis, regulation of energy metabolism, scavenging of reactive oxygen 
species, detoxification, metal sequestration and providing metabolic support to 
neurons (Fernandez-Fernandez et al., 2012; Nedergaard and Verkhratsky, 
2012; Parpura et al., 2012; Schmidt and Dringen, 2012; Tiffany-Castiglioni et 
al., 2011). 
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The BBB is a diffusion barrier that regulates the exchange of molecules between 
the blood and the brain and protects the central nervous system (CNS). The 
brain capillaries are about 50-100 times tighter compared to the peripheral 
microvessels owing to the presence of this barrier (Li et al., 2012). Although the 
primary seal of the BBB is formed by the endothelial tight junctions, majority of 
the abluminal surface of cerebral microvascular endothelium is ensheathed by 
astrocytic endfeet (Correale and Villa, 2009; Mathiisen et al., 2010). Several 
factors released by astrocytes such as transforming growth factor-???????????????
line-derived neurotrophic factor (GDNF), basic fibroblast growth factor, 
interleukin (IL) 6, and angiopoietin 1  are considered to be important for the 
induction and maintenance of the BBB (Correale and Villa, 2009). Besides, the 
astrocytic endfeet express purinergic P2Y receptors, potassium channel Kir4.1 
and water-channel protein aquaporin-4, indicating a pivotal role of these cells 
in gliovascular signaling and in regulation of brain water and electrolyte 
metabolism (Correale and Villa, 2009; Liebner et al., 2011).  
Astrocytes express a wide array of neurotrophic factors that are essential for the 
proliferation, survival and maturation of multipotent neural stem/progenitor 
cells (Barkho et al., 2006). Astrocytes, like neurons, also release a wide array of 
factors that are necessary for the growth and maturation of oligodendrocytes 
(Moore et al., 2011). Furthermore, during adult neurogenesis, neuroblasts 
migrate in the brain by sliding over astrocyte-lined tunnels (Mamber et al., 
2010; Ming and Song, 2011). Synaptogenesis is a process that occurs during 
brain development as well as in the adult brain (Kelsch et al., 2010; Pfrieger, 
2010) where astrocytes contribute immensely to the formation, maturation and 
maintenance of synapses (Faissner et al., 2010; Pfrieger, 2010). According to 
the concept of a tripartite synapse, astrocytic processes are in close vicinity of 
the neuronal pre- and post-synapse which facilitate efficient modulation of 
synaptic transmission and plasticity by communication between the two cell 
types via neurotransmitters and gliotransmitters (Faissner et al., 2010; 
Nedergaard and Verkhratsky, 2012; Verkhratsky and Parpura, 2010). On the 
other hand, rapid clearance of neurotransmitters released from nerve terminals 
is important for the survival and functioning of neurons. A number of 
transporters expressed by astrocytes function in clearance of the 
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neurotransmitters from the synaptic cleft (Coulter and Eid, 2012; Eulenburg 
and Gomeza, 2010).  
Astrocytes play a central role in regulation of extracellular K+ (Verkhratsky and 
Parpura, 2010) and express voltage-gated potassium channels as well as 
passive potassium channels (Verkhratsky and Steinhauser, 2000). These cells 
communicate with each other via gap junctions that also allow spatial K+ 
buffering required for maintaining potassium homeostasis in the brain 
(Benfenati and Ferroni, 2010). Furthermore, astrocytes express calcium-
activated potassium channels and also sodium, calcium and chloride channels 
(Deitmer and Rose, 2010; Oka et al., 2004; Verkhratsky and Steinhauser, 2000) 
that regulate the levels of these ions in the brain. The intracellular pH of brain 
cells is actively maintained in a range from 7.0 to 7.4 and is similar to the 
extracellular pH (7.1 to 7.3) in nervous tissue (Deitmer and Rose, 2010). This 
pH regulation in the brain is mediated by neurons as well as glial cells which 
possess several transporters that carry acid or base equivalents across the 
plasma membrane (Deitmer and Rose, 2010).  
Proper functioning of neurons requires sufficient production of ATP, around 
90% of which occurs via oxidative phosphorylation in the mitochondria (Cai et 
al., 2011). According to the astrocyte-neuron lactate shuttle hypothesis, 
astrocytes convert glucose to lactate and subsequently export this metabolite 
which is taken up by neurons (Fig. 1.7) (Fernandez-Fernandez et al., 2012; 
Genc et al., 2011; Parpura et al., 2012; Pellerin and Magistretti, 2012). Neurons 
oxidize lactate to pyruvate which undergoes further oxidation via the 
tricarboxylic acid (TCA) cycle in the mitochondrium along with the generation of 
ATP (Fig. 1.7) (Fernandez-Fernandez et al., 2012; Genc et al., 2011; Parpura et 
al., 2012; Pellerin and Magistretti, 2012). Besides glucose, another energy 
source in the brain is glycogen which is predominantly stored in astrocytes and 
can undergo glycogenolysis in these cells to ultimately produce and release 
lactate (Dringen et al., 1993; Obel et al., 2012). The metabolic coupling between 
astrocytes and neurons with regard to lactate is in agreement with the neuronal 
requirement of astrocytic glycogen-derived lactate for the process of memory 
formation in the hippocampus (Newman et al., 2011; Suzuki et al., 2011). 
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However, the existence of a coupling between astrocytes and neurons with 
respect to lactate is complicated by the observation that ATP generation in the 
brain during neuronal activity occurs by oxidative phosphorylation (Hall et al., 
2012) and that neurons take up glucose following brain stimulation (Dienel, 
2012; DiNuzzo et al., 2010; Mangia et al., 2011).  
 
 
Figure 1.7: Schematic representation of the metabolic coupling 
between astrocytes and neurons. Astrocytes provide neurons with 
lactate and precursors for glutathione (GSH) synthesis. ApN: 
aminopeptidase N; ?-???? ?-glutamyl transpeptidase; Mrp1: multidrug 
resistance protein, TCA: tricarboxylic acid. For details please see text.   
 
Another example of metabolic coupling between astrocytes and neurons is the 
glutamate–glutamine cycle where the astrocytic enzyme glutamine synthetase 
converts glutamate to glutamine which is subsequently released and taken up 
by neurons (Rothman et al., 2011). This glutamine can be used by neurons for 
synthesis of the neurotransmitters, glutamate and GABA (Coulter and Eid, 
2012), or for neuronal protein and GSH synthesis (Hirrlinger and Dringen, 
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2010; Schmidt and Dringen, 2012). Furthermore, the other two precursors for 
GSH synthesis, glycine and cysteine are also provided by astrocytes (Fig. 1.7) in 
a process that involves the multidrug resistance protein (Mrp) 1-mediated 
??????? ??? ???? ???? ???? ????????? ??? ???? ??????????? ??????????? ?-glutamyl 
?????????????????-GT) to form a cysteinyl-glycine dipeptide (Dringen et al., 1999; 
Fernandez-Fernandez et al., 2012; Hirrlinger and Dringen, 2010; Schmidt and 
Dringen, 2012). This dipeptide is cleaved extracellularly by the neuronal 
enzyme aminopeptidase N (ApN) to generate the two constituent amino acids 
which are taken up by neurons (Dringen et al., 2001; Fernandez-Fernandez et 
al., 2012; Hirrlinger and Dringen, 2010; Schmidt and Dringen, 2012). The 
synthesis of GSH takes place in a two-step ATP-requiring process where, at 
??????? ?-glutamylcysteine ligase generates the ?????????? ?-glutamyl-cysteine 
followed by GSH synthetase-catalyzed addition of a glycinyl moiety to the 
dipeptide to form GSH (Lu, 2012; Schmidt and Dringen, 2012). 
 
 
1.2.2.2. Oligodendrocytes 
In the CNS oligodendrocytes are specialized cells that myelinate the axons of 
neurons (Emery, 2010; Nave, 2010). Myelin extends from the plasma membrane 
of oligodendrocytes and spirally enwraps an axonal segment in the form of a 
multilamellar compact sheath (Nave and Trapp, 2008). In the brain one 
oligodendrocyte can produce up to 40 myelin segments on multiple axons with 
a capacity of myelinating oligodendrocytes to produce as much as                    
5-50×103 ??2 of membrane each day (Miron et al., 2011). Proper myelination is 
necessary for neuronal propagation of action potentials, since abnormal 
development and/or maintenance of myelin sheaths leads to nerve degeneration 
associated with disorders like MS and leukodystrophies (Lassmann et al., 2007; 
Nave, 2010; Sriram, 2011). Oligodendrocytes and neurons also communicate 
with each other through certain factors. For example, production of GDNF by 
oligodendrocytes provides trophic support to neurons (Du and Dreyfus, 
2002; Wilkins et al., 2003) while several factors released by neurons aid the 
process of myelination (Nave and Trapp, 2008). Moreover, there is also 
evidence that oligodendrocytes play a role in maintaining the nodal sodium 
Introduction 
 
21 
 
channel clusters on neurons which are necessary for saltatory conduction 
(Dupree et al., 2004; Ochab-Marcinek et al., 2009).   
The development and maturation of oligodendrocytes from oligodendrocyte 
precursor cells is a complex process regulated by extracellular signals and a 
number of intrinsic factors (Barca-Mayo and Lu, 2012; Miron et al., 2011). 
This process initiates during embryonic development and continues into 
young adult life (Barca-Mayo and Lu, 2012). Each developmental stage of 
oligodendrocytes is characterized by expression of different molecular 
markers which help in their identification (Bradl and Lassmann, 2010). 
Briefly, oligodendrocytes precursor cells differentiate into pre-myelinating 
oligodendrocytes with an intermediate pro-oligodendrocytic stage and the 
pre-myelinating oligodendrocytes finally differentiate into myelinating 
oligodendrocytes (de Castro and Bribian, 2005; Emery, 2010). During this 
process the axons release signal molecules that regulate the development of 
oligodendrocytes (Bozzali and Wrabetz, 2004). 
Amongst all types of brain cells, oligodendrocytes contain the highest amount of 
iron (Benkovic and Connor, 1993) which might be due to their requirement of 
iron for proliferation and differentiation (Todorich et al., 2009). In this regard, a 
recent study has shown that knocking out the iron efflux protein, ferroportin, in 
astrocytes negatively affects remyelination in the brain which has been 
discussed to be a consequence of decreased proliferation and/or differentiation 
of oligodendrocytes progenitor cells (Schulz et al., 2012). Oligodendrocytes can 
also use lactate as a metabolic fuel molecule or as a precursor for lipids with a 
six-fold higher rate of lipid synthesis on supply of lactate compared to 
astrocytes and neurons (Sanchez-Abarca et al., 2001). In line with this finding, 
lowering glucose availability has been shown to reduce myelination which can 
be rescued by supplying lactate (Rinholm et al., 2011). On the other hand, 
oligodendrocyte-derived products of aerobic glycolysis (pyruvate and lactate) 
have been suggested to be utilized by myelinated axons under certain 
conditions (Fünfschilling et al., 2012; Lee et al., 2012). 
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1.2.2.3. Microglia 
The term “microglia” was introduced by Pio del Rio-Hortega in 1932 
(Kettenmann et al., 2011). Microglia are the resident macrophages in the brain 
and play an important role in the innate immune response (Czeh et al., 2011; 
Kettenmann et al., 2011). In the healthy CNS ‘resting’ microglia have a ramified 
morphology consisting of a small cell body with fine cellular processes (Czeh et 
al., 2011; Kettenmann et al., 2011). The resting microglia carry out surveillance 
by constantly scanning their environment for signals that may pose a threat to 
the brain homeostasis (Czeh et al., 2011; Kettenmann et al., 2011). As a 
consequence of any disturbance in homeostasis that indicates a potential threat 
to the CNS, a phenomenon called “microglial activation” occurs which is 
characterized by changes in the microglial cell shape, gene expression and 
functions (Czeh et al., 2011; Kettenmann et al., 2011).  
Under pathological conditions, microglial cells are activated and migrate to the 
site of injury (Black and Waxman, 2012; Ohsawa and Kohsaka, 2011). Both 
activation and migration is mediated by a wide repertoire of complex signals 
which are perceived by microglia owing to the presence of numerous receptors 
on their cell surface (Kettenmann et al., 2011; Saijo et al., 2012). For example, 
CX3CL1 is a chemokine which is either membrane-bound or soluble that is 
expressed by neurons and modulates microglial activity by interacting with the 
CX3CL1 receptor present on the latter cell type (Marchesi et al., 2010; Pabon et 
al., 2011). Activated microglia initiate immune responses such as phagocytosis, 
antigen processing and presentation and the production of a number of factors 
(Kettenmann et al., 2011; Smith et al., 2012; Sosa and Forsthuber, 2011).  
Microglia produce cytotoxic factors (e.g. nitric oxide, reactive oxygen species), 
neurotrophic factors (e.g. brain-derived neurotrophic factor, nerve growth 
factor) as well as pro- (IL-1, tumor necrosis factor-???????????-inflammatory (IL-
4 and IL-10) cytokines (Czeh et al., 2011; Kettenmann et al., 2011; Smith et al., 
2012). During brain development, these cells also regulate apoptosis, cell 
proliferation, angiogenesis and neuronal differentiation (Czeh et al., 2011; Harry 
and Kraft, 2012; Pont-Lezica et al., 2011). Finally, microglia play a role in 
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restructuring of neuronal circuits by synaptic modification and elimination 
(Tremblay and Majewska, 2011; Tremblay et al., 2011). 
  
 
1.2.3. Brain cells in diseases 
Under normal physiological conditions, an efficient cross-talk between different 
brain cells is essential for optimal brain functions (Garden and La Spada, 
2012). A dysfunction in such an intercellular communication in pathology may 
play a role in initiation and progression of diseases. A few examples of diseases 
of the CNS and the interplay between different brain cell types in their 
pathology are briefly described in this section. 
AD patients suffer from a progressive memory loss and dysfunction of higher 
cognitive domains (Stopford et al., 2012). This neurodegenerative disease is 
?????????????? ??? ???????????? ???? ??????????? ??? ?-???????? ????? ????????? ????
formation of neurofibrillary tangles that ultimately lead to neuronal death 
(Benilova et al., 2012; Wesson et al., 2011). Besides these hallmarks of the 
disease, inflammation is also seen in AD brain (Broussard et al., 2012; Wyss-
Coray, 2006; Wyss-Coray and Rogers, 2012). Although the precise mechanism 
?????????????????????????????????????????????????????????????????????????????????
a cascade of hemichannel activation wherein microglial and astroglial release of 
glutamate as well as ATP promotes neuronal death (Orellana et al., 2011a; 
Orellana et al., 2011b)???????????????????????????????????????????????????????
astrocytes and microglia which in turn release pro- and anti-inflammatory 
mediators resulting in neuroinflammation (Broussard et al., 2012; Wyss-Coray 
and Rogers, 2012). Although oligodendrocytes have not been extensively studied 
????? ???????? ???????????????????????????? ??? ?????????????????????????????????
been reported in vitro as well as in vivo (Mitew et al., 2010; Roth et al., 2005). 
Parkinson’s disease (PD) is a neurodegenerative disorder that affects motor 
functions (Fasano et al., 2012). In PD, dopaminergic neurons in the substantia 
??????????????????????????????????????????????-synuclein inclusions in neuronal 
cell bodies and axons (Halliday and Stevens, 2011; Steiner et al., 2011). 
However, during the progression of the disease, these inclusions are also seen 
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in protoplasmic astrocytes which in turn activate microglia by the release of 
cytokines and chemokines (Halliday and Stevens, 2011). These activated 
phagocytotic microglial cells target neurons and also cause inflammation in PD 
brains (Halliday and Stevens, 2011; Politis et al., 2012). During later stage of 
the disease, the non-??????????????????????????????????????????????-synuclein 
(Halliday and Stevens, 2011) and could further contribute to neuronal death.  
MS is an autoimmune inflammatory demyelinating disorder of the CNS 
(Lassmann et al., 2007; Sriram, 2011). In MS astrocytes and microglia are 
considered to elicit an inflammatory response and majorly target 
oligodendrocytes and neurons (Chastain et al., 2011; Miljkovic et al., 2011). 
Moreover, a disruption in the BBB as well as the blood-cerebrospinal fluid 
barrier in MS facilitates infiltration of leukocytes into the brain which further 
damage oligodendrocytes and affect myelin (Alvarez et al., 2011). An extensive 
loss in myelin and the underlying axons observed in MS (Bradl and Lassmann, 
2010; Sriram, 2011) is detrimental as demyelination of neurons can affect 
memory and cognitive functions (Fields, 2008; Huang et al., 2009). 
 
 
1.3. Formaldehyde and brain 
The BBB is a physical obstruction that monitors the entry of compounds into 
the brain tissue. However, methanol and formaldehyde from blood can easily 
cross this barrier owing to their small size and uncharged nature. The 
concentration of formaldehyde in the healthy brain has been reported to be 0.2-
0.4 mM (Tong et al., 2012) which may reflect the balance between 
formaldehyde-generating and -disposing processes in the brain. This section 
deals with the production and metabolism of formaldehyde in the brain, 
involvement of formaldehyde in pathology of some neurodegenerative diseases 
and the neurotoxicity of formaldehyde. 
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1.3.1. Presence of formaldehyde-generating and -disposing enzymes  
Several reports have demonstrated the presence of enzymes that produce and 
metabolize formaldehyde in the brain on the mRNA or protein level (Table 1.3). 
These reports suggest that local formaldehyde generation can occur in the brain 
and that the brain cells have the potential to dispose this formaldehyde. 
However, unlike other enzymes, the expression of ADH1 in the brain has been 
controversial since this dehydrogenase was not detected in some investigations 
(Galter et al., 2003; Julia et al., 1987). 
  
 
1.3.2. Formaldehyde in pathology of neurodegenerative diseases 
The observation that certain neurodegenerative diseases like AD and MS are 
associated with an increase in formaldehyde-generating enzymes (Section 1.1.4) 
has led to postulation of hypotheses wherein elevated formaldehyde levels are 
linked to pathology of these diseases. Monte (2010) suggested that 
formaldehyde methylates proteins such as tau protein (in AD) or myelin basic 
protein (in MS) which in turn elicits an immune response by the body (Monte, 
2010). In line with this hypothesis, inhibition of SSAO in a murine mouse 
model of MS has been shown to reduce the incidence and severity of this 
disease (Wang et al., 2006) which may, at least in part, be due to lowering of 
formaldehyde generation. Also, some human subjects who suffered from 
methanol poisoning developed symptoms of MS which has been discussed to be 
an effect of methanol oxidation to formaldehyde (Henzi, 1984; Schwyzer and 
Henzi, 1983) and the subsequent modification of proteins as described above. 
Furthermore, formaldehyde exposure has been indicated to be a risk factor for 
development of amyotrophic lateral sclerosis (Weisskopf et al., 2009), another 
neurodegenerative motor neuron disease (Kiernan et al., 2011). 
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Table 1.3: Formaldehyde-producing and -metabolizing enzymes in 
the brain. 
 
Enzymes 
 
Brain region  
 
References 
 
 
Formaldehyde generation 
 
ADH1 Cerebellum, 
hippocampus, cerebral 
cortex  
Martinez et al., 2001 
 
 
 
Catalase Cerebellum, olfactory 
bulb, hippocampus,  
Schad et al., 2003;  
Zimatkin and Lindros, 1996 
 
SSAO/ 
VAP1 
Meningeal and 
parenchymal blood 
vessels 
 
Ferrer et al., 2002;  
Unzeta et al., 2007;  
Valente et al., 2012  
LSD1 Hippocampus, cerebral 
cortex 
 
 
Sun et al., 2010;  
Zhang et al., 2010;  
Zibetti et al., 2010 
JHDM Total brain Fukuda et al., 2011;  
Wolf et al., 2007 
 
 
Formaldehyde oxidation 
 
ADH3 Cerebral cortex, 
cerebellum, 
hippocampus 
 
Galter et al., 2003;  
Iborra et al., 1992;  
Julia et al., 1987 
ALDH2 Total brain Alnouti and Klaassen, 2008; 
Stewart et al., 1996 
 
 
Formate oxidation 
 
MTHFD1 Total brain Anthony and Heintz, 2007; 
MacFarlane et al., 2009 
 
MTHFD1L Total brain Prasannan et al., 2003 
 
ALDH1L1 Cerebral cortex, basal 
ganglia, cerebellum 
Cahoy et al., 2008;  
Neymeyer et al., 1997 
 
ALDH1L2 Total brain Krupenko et al., 2010 
 
 
 
Yu (2001) proposed that in AD, SSAO-mediated formaldehyde generation can 
induce ?? cross-linkage, deposition and subsequently result in plaque 
formation adjacent to the cerebrovessels. Furthermore, it is suggested that in 
AD formaldehyde may cause cytotoxicity, inducing inflammation and release of 
more SSAO, thereby producing a cascade of toxic cycles (Yu, 2001). An indirect 
indication for a putative role of formaldehyde in AD pathology is found in two 
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???????? ?????? ????????????? ????????? ?? aggregation in vitro (Chen et al., 
2007) and SSAO was shown to co-localize with ?? deposits in AD brain (Jiang 
et al., 2008). On the other hand, increased formaldehyde levels in the brain and 
cerebrospinal fluid of patients suffering from AD and MS (Khokhlov et al., 1989 
cited in Miao and He, 2012; Tong et al., 2012; Tong et al., 2011) are indicative 
of the involvement of formaldehyde in the pathology of these diseases.  
Besides neurodegenerative diseases, aging and diabetes are also characterized 
by elevated concentration of formaldehyde in brain (Tong et al., 2012). In aging 
an increase in cerebral protein carboxymethylation occurs (Sellinger et al., 
1988) which can serve as a source of methanol and hence of formaldehyde. On 
the other hand, elevated SSAO activity in diabetes (Boomsma et al., 2005; 
Gronvall-Nordquist et al., 2001; Karadi et al., 2002; Meszaros et al., 1999; 
Obata, 2006) may contribute to the observed increase in brain formaldehyde 
levels in diabetes mouse models (Tong et al., 2012). 
 
 
1.3.3. Formaldehyde neurotoxicity 
The neurotoxic potential of formaldehyde is well-known (Songur et al., 2010). 
Alterations in brain morphology following formaldehyde exposure in rats 
include a decrease in the number of neurons and a reduction in the volume of 
brain hemispheres (Aslan et al., 2006; Gurel et al., 2005; Sarsilmaz et al., 2007; 
Songur et al., 2010). Formaldehyde exposure also compromises the 
antioxidative defense of the brain by decreasing the level of GSH and also 
activities of the antioxidative enzymes superoxide dismutase and catalase 
(Gurel et al., 2005; Lu et al., 2008b; Songur et al., 2008; Zararsiz et al., 2006; 
Zararsiz et al., 2007; Zararsiz et al., 2011). This compromised antioxidative 
capacity is accompanied by an increase in nitric oxide levels and also in the 
amounts of markers of oxidative stress such as malondialdehyde and protein 
carbonyls (Gurel et al., 2005; Lu et al., 2008b; Songur et al., 2008; Zararsiz et 
al., 2006; Zararsiz et al., 2007). Also, PC12 cells treated with formaldehyde 
exhibit endoplasmic reticulum stress, decrease in levels of the antioxidant 
proteins thioredoxin and paraoxonase 1, reduction in tyrosine hydroxylase 
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expression and apoptosis (Lee et al., 2008; Luo et al., 2012; Tang et al., 2011). 
An increase in apoptotic events has also been observed, in vivo in brains of 
formaldehyde-treated rats (Zararsiz et al., 2006; Zararsiz et al., 2007). 
Formaldehyde application blocks the N-methyl-D-aspartate (NMDA) receptor 
(Tong et al., 2012) which is considered to be crucial for memory formation 
(Mayford et al., 2012; Timofeeva and Levin, 2011). In line with this finding, 
exposure to formaldehyde has been shown to affect behavior, memory and 
learning (Lu et al., 2008b; Malek et al., 2003; Pitten et al., 2000; Sorg et al., 
2004; Tong et al., 2012; Tong et al., 2011; Turkoglu et al., 2008; Usanmaz et 
al., 2002). Furthermore, formaldehyde alters the expression of glutamate 
receptor and decreases glutamate uptake in cultured astrocytes (Song et al., 
2010). Although the above mentioned toxicity of formaldehyde treatment, both 
in vivo and in vitro, could be due to formaldehyde, per se, there is a likelihood 
that formate, the oxidation product of formaldehyde, may contribute, at least in 
part, to the observed toxicity. Formic acid is known to inhibit complex IV of the 
respiratory chain (Nicholls, 1975) which would diminish ATP production by 
oxidative phosphorylation (Wallace et al., 1997). Besides, formic acid has been 
shown to cause neuronal death in brain slices (Kapur et al., 2007) as well as in 
primary neural cultures (Dorman et al., 1993). 
 
 
1.4. Aim of the thesis 
Formaldehyde is implied to play a role in the pathology of several 
neurodegenerative diseases, yet little is known about the metabolism of 
formaldehyde in brain cells and on the effects of formaldehyde exposure on 
brain cells. Therefore, this thesis aims to focus on the following consequences of 
formaldehyde application on cell culture model systems for neural cells, 
namely, astrocyte-rich primary cultures (Lange et al., 2012), primary cultures of 
cerebellar granule neurons (Drejer et al., 1985) and the oligodendroglial cell-line 
OLN-93 (Richter-Landsberg and Heinrich, 1996): ? Assessment of the vulnerability of different brain cell-types to 
formaldehyde-induced toxicity. 
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? Investigation of the capacity of brain cells to metabolize exogenously 
applied formaldehyde by measuring formaldehyde, formate and 
methanol. ? Alterations in glucose metabolism of cultured brain cells as 
accumulation of formate within cells may inhibit complex IV (Nicholls, 
1975) of the respiratory chain and consequently enhance glycolysis. ? Effect of formaldehyde on GSH homeostasis in brain cells, since 
formaldehyde metabolism by ADH3 is GSH-dependent (Harris et al., 
2003; MacAllister et al., 2011; Staab et al., 2009; Thompson et al., 2010) 
and exposure to this aldehyde results in oxidative stress in the brain 
(Gurel et al., 2005; Lu et al., 2008b; Songur et al., 2008; Zararsiz et al., 
2006; Zararsiz et al., 2007). 
These studies will give an insight into the metabolic consequences of a 
formaldehyde exposure in vitro which is likely to also have physiological 
relevance in vivo.  
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Abstract 
Primary cultures of astrocytes and neurons are frequently used to investigate 
metabolic properties of these two important brain cell types. Here we describe 
methods to generate primary cultures that are highly enriched in astrocytes or 
cerebellar granule neurons. These cultures are good model systems to 
investigate the basal metabolism of astrocytes and neurons as well as 
metabolite export from these cells. As examples for such studies, we describe 
here in detail the robust practical procedures that we use to investigate cellular 
glucose consumption and lactate production as well as the cellular contents 
and the export of glutathione from cultured brain cells. In this context we also 
describe some viability assays that are useful to confirm that a given 
experimental treatment is not toxic for cultured neural cells.  
 
Key words: astrocytes, metabolite export, glucose, glycolytic flux, GSH, 
neurons, lactate, viability 
 
Running head: Metabolism of cultured brain cells 
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1. Introduction 
The brain is a complex organ that consists of various cell types which all have 
important and essential functions. While neurons are mainly responsible for the 
transmission and processing of information, astrocytes have many supporting, 
protective and modulatory functions (1-3). The complexity of the brain makes it 
rather difficult to gain information on the metabolic potential of one brain cell 
type by direct quantification of metabolites from brain tissue. In most cases 
such analysis identifies neither the cellular origin of the metabolite of interest 
nor whether the metabolite was located in a given cell type or extracellularly. In 
order to investigate the metabolic potential of the different types of brain cells, 
primary cell cultures are frequently used that are enriched for only one type of 
brain cells. Such cultures allow metabolic studies of one brain cell type in the 
absence of the other cell types that constitute the brain. For example, primary 
cultures of astrocytes have been used extensively to investigate metabolic 
properties of this cell type in order to understand the functions of astrocytes (4). 
However, it should be considered that highly enriched cell cultures have the 
disadvantage that the potential modulation of metabolic properties of one type 
of brain cells by another is prevented. In addition, cultured cells do not 
necessarily present the same metabolic properties as brain cells in vivo. 
Therefore, while studies in cell cultures can provide valuable insights in the 
metabolic potential of brain cells, the extrapolation to the in vivo situation has 
to be done carefully and should, if possible, be verified in more complex or even 
intact neural systems (see chapters______ of this book). 
Many protocols have been used to prepare neural cell cultures that are strongly 
enriched in either astrocytes or neurons. We describe here in detail the 
methods we use to prepare astrocyte-rich primary cultures (APCs) and 
cerebellar granule neuron cultures (CGNCs) that are based on the protocols 
described by Hamprecht and Löffler (5) and by Anggono and colleagues (6). 
APCs are highly enriched for astrocytes as demonstrated by 
immunocytochemical staining for the astrocyte marker protein, glial fibrillary 
acidic protein (GFAP) (Fig. 1C), while hardly any cell in these cultures is positive 
for the neuron-specific marker protein microtubule-associated protein 2 (MAP-
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2; Fig. 1C). In contrast, most cells in CGNCs express MAP-2 and only a few cells 
in these cultures are positive for GFAP (Fig. 1D). The detailed methods to 
prepare and maintain APCs and CGNCs are described below in chapter 2. 
To confirm that data from experiments designed to investigate metabolic 
properties of cultured cells reflect the metabolism of viable cells, it is essential 
to test for a potential compromised cell viability of a given experimental 
paradigm. In addition to frequent microscopic inspection of the cell morphology 
and determination of the protein content of the adherent cultured cells, we 
investigate routinely for each experimental condition whether the cell 
membrane integrity is compromised. This is done by determining the 
extracellular activity of the cytosolic enzyme lactate dehydrogenase (LDH) (7) 
and by investigating the permeability of the cell membranes for the fluorescent 
dye propidium iodide (PI) (8). The detailed methods for these two viability assays 
are presented in chapter 4. 
We frequently use cell cultures as models to investigate the metabolism of brain 
cells. As examples for such studies we describe here the determination of 
glucose consumption and lactate release by APCs and CGNCs as well as the 
quantification of the cellular glutathione (GSH) content and of the GSH export 
from these cells. The incubation conditions recommended for such metabolic 
studies as well as the microtiter plate-based colorimetric assays that we use for 
the quantification of glucose, lactate and GSH are described in detail in 
chapters 3 and 5-7. 
 
 
2. Preparation of primary cultures from rat brain 
Infrastructure: Special infrastructure is required for the generation and 
maintenance of primary brain cell cultures. An animal breeding facility or a 
room for housing company-delivered animals (either pregnant or mother with 
pups) is a pre-requisite for the preparation of primary cell cultures. Animal 
handling has to be conducted in accordance with the valid guidelines for care 
and use of laboratory animals and has to be licensed by the appropriate 
authorities. 
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Special cell culturing infrastructure is required for the preparation and the 
maintenance of the primary cell cultures. This includes a laminar air flow 
bench for sterile work, an incubator with CO2 gas supply for culturing of cells in 
carbonate-buffered media, a centrifuge for spinning down cell suspensions, 
fridge and freezer for storage of media and solutions as well as a water bath for 
pre-warming media to 37°C. Since the cells are kept in culture for several 
weeks, it is mandatory to perform all cell culturing steps under sterile 
conditions. For a regular monitoring of cell growth and morphology during 
culturing and experimental incubations a microscope is required, preferably in 
close vicinity of the cell incubator to avoid transport-induced fluctuations in 
temperature or pH of the culture medium. Used cell culture solutions, media 
and cell culture waste should be disposed off after autoclaving. Animal cadavers 
should be disposed according to the appropriate regulations of the country and 
the scientific institution. 
 
 
2.1. Astrocyte-rich primary cultures (APCs) from rat brain 
APCs are prepared from the brains of newborn Wistar rats that have an age of 
maximal 24 h. 
 
 
2.1.1. Materials and solutions 
Materials: Dulbecco’s modified Eagle’s medium (DMEM), ethanol (70%), fetal 
calf serum (FCS), D-glucose, NaCl, KCl, KH2PO4, Na2HPO4, penicillin G, 
streptomycin sulphate, sucrose, sterile disposable filter units (0.2 µm), surgical 
scissors (length: 15 cm), two bent forceps with blunt tips (length: 15 cm), sterile 
(autoclaved) nylon mesh filter bags (size of around 1.5 x 4 cm) prepared by 
heat-induced sealing of nylon meshes (4 x 4 cm) of pore diameters of 210 µm or 
132 µm (Sefar, Heiden, Switzerland), Neubauer counting chamber, sterile 10 mL 
pipettes, sterile 50 mL centrifugation tubes, sterile 5 cm, 10 cm and 24-well cell 
culture plates. 
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APC preparation solution: The solution contains 137 mM NaCl, 5.4 mM KCl, 
0.22 mM KH2PO4, 0.17 mM Na2HPO4, 5 mM glucose, 58.4 mM sucrose, 200 
U/mL penicillin G and 200 µg/mL streptomycin sulphate. This solution should 
be filtered sterile through a 0.2 µm sterile filter and can be stored at 4°C for a 
few months. 
 
APC medium: DMEM containing 25 mM D-glucose, 44 mM sodium 
bicarbonate, 1 mM pyruvate, 200 U/L penicillin G and 200 µg/L streptomycin 
sulfate should be sterile filtered (0.2 µm filter) and supplemented with 10% (v/v) 
of sterile FCS. This sterile culture medium can be stored at 4°C for a month. 
 
 
2.1.2. Method 
1. Clean the laminar air flow bench with 70% ethanol and sterilize it with UV 
light for 30 min prior to any use for cell culture work.  
2. Place three 10 cm cell culture dishes (A-C) containing cold APC preparation 
solution (dish A: 20 mL, dish B: 10 mL, dish C: 10 mL) on a tray filled with 
ice under the bench. In dishes B and C put one nylon mesh filter bag of pore 
diameters of 210 µm and 132 µm, respectively. Stack 5 cm dishes in the 
bench, one for each brain. Fill a glass dish (4-5 cm high) (dish D) with pre-
warmed preparation solution. Sterilize forceps and surgical scissors by 
rinsing with 70% ethanol and a careful flame treatment. Place the scissors 
and forceps on a metal stand on the bench, avoiding contact of the sterile 
parts with the surface of the bench.  
3. Take one new-born rat with a pair of forceps and briefly immerse the animal 
in pre-warmed preparation solution (dish D). Decapitate the animal with 
scissors and collect the head in a 5 cm cell culture dish. Remove the entire 
brain of the animal by carefully squeezing its head by using two forceps 
from mouth to neck, collect the brain and transfer it into the ice-cold 
preparation solution in dish A. Repeat these steps until all rat brains (use at 
least 3 brains and up to 15 brains) are collected in dish A. 
4. Transfer 3-5 rat brains into the 210 µm nylon mesh filter bag in dish B and 
pass the brains through the net into dish B by gentle squeezing the brains 
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through the nylon mesh using bent forceps with blunt tips. Repeat this until 
all brains have been passed through the 210 µm nylon mesh filter bag. 
Finally, filter the remaining preparation solution from dish A through the 
210 µm nylon mesh bag into dish B using a 10 mL pipette. 
5. Pass the total 30 mL cell suspension from dish B through the 132 µm nylon 
mesh bag into dish C using a 10 mL pipette. Ensure that all material has 
passed through the mesh.  
6. Transfer the total 40 mL cell suspension into one 50 mL centrifugation tube 
and spin down cells with 400 g for 5 min at 4°C. Carefully remove the 
supernatant and resuspend the cell pellet in pre-warmed (37°C) culture 
medium (2 mL per brain).  
7. One neonatal rat brain will yield approximately 30 million viable cells. Count 
the harvested cells in a Neubauer counting chamber and add culture 
medium to the cell suspension to obtain a seeding density to 150,000 cells 
per cm2. Plate the cell suspension in cell culture dishes (24-well dish: 
300,000 viable cells in 1 mL medium; 5 cm dish: 3 million viable cells in 5 
mL medium). 
8. Maintain the cultured cells in a cell incubator at 37°C with an atmosphere 
that contains 90% air, 10% CO2 and 100% relative humidity. The APC 
medium should be renewed every seventh day of cultivation. APCs reach 
confluency after about 10 d and the cultures can be used for experiments 
between 14-28 d after seeding. 
 
 
2.1.3. Results and Notes 
1. It is essential to routinely characterize the cultures by microscopic 
inspection and by immunocytochemical staining using antibodies for cell-
type specific markers. Fig. 1A shows a phase contrast image of an APC. 
Immunocytochemical staining of APCs revealed that around 95% of the cells 
in these cultures are positive for the astrocyte marker protein GFAP (Fig. 
1C). However, APCs also contain low numbers of other types of glial cells 
(microglia, oligodendrocytes and ependymal cells) (5,9,10), but hardly any 
cells that express the neuronal marker MAP-2 (Fig. 1C). 
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Figure 1: Phase contrast images (A,B) and immunocytochemical 
staining (C,D) of APCs (A,C) or CGNCs (B,D). Immunocytochemistry 
(C,D) was performed for the presence of the astrocytic marker protein 
GFAP (green) and the neuronal marker protein MAP-2 (red). The cell 
nuclei are co-stained with DAPI (blue). Immunocytochemistry was 
performed as previously described (32) by using rabbit anti-GFAP 
(1:500), Cy-2-coupled anti-rabbit IgG (1:200), mouse anti-MAP-2 (1:250) 
and Cy3-coupled anti-mouse IgG (1:200). The scale bar in D represents 
50 µm and applies to all panels. 
 
 
2. The protocol described here can also be used to prepare APCs from the 
brains of newborn mice. However, substantially lower numbers of cells will 
be obtained from one mouse brain compared to a rat brain.  
3. This protocol can also be used to prepare astrocytes from a specific brain 
region like e.g. the cortex. In this case, the brain has to be carefully 
dissected out of the skull and the brain region of interest should be 
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harvested. After collection of the desired brain region from several brains, 
the preparation can be done as described above.  
4. In case a cell incubator has to be used that supplies less than 10% CO2, the 
APC medium can be adjusted by lowering the sodium bicarbonate 
concentration to establish the desired pH. The concentration of NaCl should 
be increased accordingly to maintain a constant osmolarity. 
5. Depending on the type of metabolic experiment to be performed it should be 
considered to feed APCs with fresh culture medium (with or without serum) 
one day prior to the experiment to replenish the cells with nutrients.  
6. For immunocytochemical staining the use of sub-confluent APCs should be 
considered, since individual astrocytes are easier to distinguish from each 
other in such cultures. 
7. Metabolite contents and enzyme activities of cultured brain cells are 
frequently normalized on the protein contents of the cells. To determine the 
protein content per well of APCs or CGNCs in wells of 24-well dishes, we 
solubilize the cells for 2 h in 200 µL of 0.5 M NaOH and determine the 
protein content in such lysates by the Lowry method (11).  
 
 
2.2. Cerebellar granule neuron primary cultures (CGNCs) from rat 
brain 
CGNCs are prepared from the brains of 7 d old Wistar rats (6). Up to 7 cerebella 
can be harvested for one procedure. If more cells are needed, it is recommended 
to perform the preparation twice. In contrast to many other types of cultured 
neurons, CGNCs require a high concentration of K+ for maintenance. Therefore, 
culture media and buffers for CGNCs are supplemented with additional KCl.  
 
 
2.2.1. Materials and solutions 
Materials: Bovine serum albumin (BSA), cytosine ?-D-arabinofuranoside (Ara-
C), deoxyribonuclease, D-glucose, Earle´s balanced salt solution (EBSS), 
ethanol (70%), L-glutamine, FCS, KCl, KH2PO4, K2HPO4, minimal essential 
medium (MEM), MgSO4, NaCl, penicillin G, poly-D-lysine (PDL), soybean trypsin 
Methods: Publication/Manuscript 1 
 
62 
 
inhibitor, streptomycin sulphate, trypsin, sterile (autoclaved) glass pipettes, a 
pair each of bent (length: 15 cm) and straight surgical scissors (length: 14.5 
cm), bent (length: 11 cm) and straight (length: 13 cm) forceps, Neubauer 
counting chamber, sterile scalpel, sterile 5 cm, 10 cm and 24-well cell culture 
dishes. 
 
Coating of cell culture dishes with poly-D-lysine (PDL): Cerebellar granule 
neurons will attach very well to cell culture dishes that are covered with positive 
charges due to a coating with PDL. Prepare a sterile 15 µg/mL PDL 
hydrobromide (molecular weight: 30,000 - 70,000) solution in pure water. The 
solution can be stored at 4°C for a few weeks. Cell culture dishes are coated 
with PDL by 2 h incubation with an appropriate volume of the sterile PDL 
solution at room temperature under sterile conditions. Subsequently, the PDL 
solution is removed, the wells are washed once with sterile water and the cell 
cultures dishes are dried under sterile conditions. Coated sterile cell cultures 
dishes can be stored at 4°C for a few days. 
 
Modified Earle’s balanced salt solution (mEBSS): Dissolve 4% (w/v) BSA and 
3 mM MgSO4 in EBSS and filter the solution sterile. Aliquots of this solution 
can be stored in sterile tubes at -20°C for several months. 
 
Phosphate-buffered saline (PBS): Prepare a sterile 10 mM potassium 
phosphate buffer pH 7.4 containing 150 mM NaCl. This solution can be stored 
for months at 4°C. 
 
CGNC preparation buffer: Prepare for each CGNC preparation 100 mL of a 
fresh sterile solution of 14 mM D-glucose, 60 mM MgSO4 and 0.3% (w/v) BSA in 
PBS. 
 
Trypsin solution: Prepare 20 mL of a sterile solution of 0.25% (w/v) trypsin in 
CGNC preparation buffer shortly before each CGNC preparation. 
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Trypsin inhibitor solution: Dissolve 600 U deoxyribonuclease, 0.5 mg soybean 
trypsin inhibitor and 1.5 mM MgSO4 in 10 mL of CGNC preparation buffer 
shortly before each CGNC preparation. Before use dilute 3.2 mL of this solution 
with 16.8 mL CGNC preparation buffer to obtain 20 mL of the sterile diluted 
trypsin inhibitor solution. 
 
CGNC medium: Prepare MEM containing 26 mM sodium bicarbonate, 30 mM 
D-glucose, 25 mM KCl, 2 mM L-glutamine, 200 U/L penicillin G, 200 µg/L 
streptomycin sulfate. Filter it sterile (0.2 µm filter) and add 10% (v/v) heat-
inactivated FCS. Heat-inactivated FCS is prepared by incubation of a bottle of 
FCS in a water bath at 55°C for 1 h (aliquots of 50 mL can be stored frozen at -
20°C until use). The CGNC medium can be stored at 4°C for up to one month. 
In addition, prepare culture medium which is supplemented with 10 µM Ara-C.  
 
 
2.2.2. Method 
1. Clean the laminar air flow bench with 70% ethanol and sterilize it with UV 
light for 30 min prior to any use for cell culture work. 
2. Put 5 mL CGNC preparation buffer in one 5 cm cell culture dish to collect 
the cerebella. Sterilize forceps and surgical scissors by rinsing with 70% 
ethanol and careful flame treatment. 
3. Warm all required solutions to room temperature and perform all 
preparations steps at this temperature. 
4. Decapitate the animals with scissors and collect the heads in 10 cm cell 
cultures dishes. Open the skull with surgical scissors and dissect the 
cerebellum with the bent forceps. Place the extracted cerebella in the 5 cm 
cell culture dish containing CGNC preparation buffer. Repeat this step until 
up to 7 cerebella are collected in preparation buffer. 
5. Transfer all the cerebella in a new 5 cm dish and cut the tissue into small 
pieces with a scalpel.  
6. Transfer the minced cerebella to 20 mL trypsin solution and incubate at 
37°C until the tissue is digested (approximately 20 min). Regularly shake the 
solution gently to improve the access of the trypsin to the tissue.  
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7. Flame polish 3 sterile glass pipettes using the Bunsen burner flame under 
the bench. Narrow the necks of two pipettes using the flame to obtain one 
fine and one medium bore. Flame-polish the third pipette-neck only to 
remove all sharp edges of the glass.  
8. After the trypsinization is completed add 20 mL of diluted trypsin inhibitor 
solution to the digest and centrifuge at 800 g for 1 min at room temperature.  
9. Remove the supernatant and resuspend the pellet in about 2 mL of the 
trypsin inhibitor solution using the wide-bore glass pipette. Thereafter, 
consecutively use the medium and fine narrow bore pipettes to triturate the 
cells thoroughly for generation of a single cell suspension. 
10.Layer the cell suspension carefully above 12 mL of the mEBSS solution and 
centrifuge for 5 min at 1300 g and room temperature. Gently remove the 
supernatant and thoroughly resuspend the pellet in 2 to 4 mL CGNC 
medium.  
11.One rat cerebellum will yield approximately 30 million viable cells. Count 
the harvested cells in a Neubauer cell counting chamber and adjust the cell 
suspension with CGNC medium to the desired cell number (375,000 cells 
per cm2) and plate the cell suspension in cell culture dishes (24-well dish: 
0.75 million viable cells in 1 mL medium). 
12.Incubate the cultured cells in a cell incubator at 37°C with an atmosphere 
that contains 95% air, 5% CO2 and 100% relative humidity. The culture 
medium should be changed after 24 h of incubation to CGNC medium 
containing 10 µM Ara-C to inhibit the proliferation of contaminating cells 
(mainly astrocytes). The cultures can be used in the range between 7- 12 
days after seeding. 
 
 
2.2.3. Results and Notes 
1. It is essential to routinely characterize the cultures by microscopic 
inspection and by immunocytochemical characterization for cell type specific 
marker proteins. Fig. 1B shows a phase contrast image of a CGNC. 
Immunocytochemical staining of these cultures revealed that around 99% of 
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the cells in these cultures are MAP-2 positive and only 1% of the cells 
express GFAP (Fig. 1D).  
2. CGNCs are more delicate to handle compared to APCs. Therefore, it is 
recommended to be very careful when changing the medium especially after 
experimental incubations, since the treatment might already have stressed 
the cells and they may detach easily. 
 
 
3. Incubation of cultured brain cells for short-term metabolic 
studies 
Metabolic studies on cultured brain cells can be performed in the complex cell 
culture media used to maintain the cultures. However, due to the large number 
of compounds present in complex culture media, especially if undefined 
protein-containing serum is added, an interference of media components with 
uptake, metabolism and/or export of substrates and metabolites is difficult to 
exclude. For example the high glucose content of many commercial culture 
media (25 mM) prevents a reliable determination of the cellular glucose 
consumption in the hour range, while the cystine present in such media reacts 
chemically with GSH exported from cells to form mixed cysteine-GSH disulfide. 
A good alternative to culture media, at least for short time metabolic studies, 
are defined isotonic incubation buffers that can be used to incubate APCs and 
CGNCs for hours without compromising cell viability. Here we describe the 
buffers and treatments that we use regularly to investigate glucose and GSH 
metabolism of cultured brain cells in the hour range.  
 
 
3.1. Materials and solutions 
Materials: CaCl2, 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), 
D-Glucose, KCl, MgCl2, NaCl, Na2HPO4, NaOH. 
 
Incubation buffer (IB): Prepare a solution containing 1.8 mM CaCl2, 1 mM 
MgCl2, 5.4 mM KCl, 145 mM NaCl, 0.8 mM Na2HPO4, 20 mM HEPES and 5 mM 
glucose, pH 7.4 at 37?C. For experiments on CGNCs it is necessary to 
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supplement the IB with additional KCl to a final concentration of 30 mM. If the 
incubation is to be performed at 4?C, adjust the pH of IB to 7.4 at this 
temperature. IB should not be stored for longer than 1 week at 4?C, since 
microbial contamination as well as formation of salt precipitates cannot be 
excluded for longer storage periods. 
 
 
3.2. Method 
1. Dissolve all compounds that should be applied to the cultured cells in IB to 
establish the appropriate final concentrations of test substances in the 
incubation medium. If test compounds cannot be directly dissolved in IB but 
have to be taken from a concentrated stock solution in an organic solvent 
(e.g. dimethyl sulfoxide or ethanol), always include the solvent in the 
appropriate final concentration as an additional control. Before starting the 
incubation, ensure that all incubation media are warmed up to 37°C, 
preferably by using a water bath. 
2. Place a 24-well culture plate containing cells onto a metal grid that is 
warmed to 37°C in a water bath (the water level should be a few millimeters 
above the grid) and aspirate the culture medium. Wash the cells twice with 1 
mL pre-warmed (37?C) IB and then add a defined volume of pre-warmed 
incubation medium containing the test compounds of interest. The volume 
of incubation medium can be varied between 200 µL and 1 mL per well, 
depending on the design of the experiment, the costs of the test compounds 
and the sensitivity of the assay systems that will be applied. Use triplicate 
wells for each condition to confirm reproducibility. For experimental 
incubation of cultured neurons use only one washing step to lower the risk 
of cell detachment from the culture plate.  
3. Transfer the plate to an incubator set at 37?C with CO2-free humidified 
atmosphere and incubate the plate for the desired incubation period.  
4. To terminate the incubation, harvest the incubation media and store them 
at the appropriate storage temperature until further analysis. For 
determination of cellular metabolites (e.g., glutathione) or cellular enzyme 
activities (e.g., LDH), wash the cells twice with 1 mL unsterile ice-cold PBS 
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to stop transport processes and cell metabolism before applying an 
appropriate volume of lysis solution to the washed cells. 
 
 
3.3. Notes 
The procedure described above can be used for an incubation of cultured cells 
for up to 6 h, unless the viability of cells is compromised. For long incubation 
periods, all washing and incubation steps should be performed under sterile 
conditions to avoid interference by microbial contamination.  
1. Careful treatment of the cells during all washing and incubation steps is 
essential to avoid detachment of cells and damage of the cell layer. Ensure 
that temperature and pH of all solutions are properly adjusted to the desired 
values.  
2. For incubations at a given temperature always use IB the pH of which was 
adjusted to the desired temperature for washing and for incubations.  
3. Depending on the type of experiment and the type of metabolite measured, it 
is important to feed the cells with fresh culture medium 1 d prior to 
performance of the experiment to replenish the cells with nutrients.  
4. In the case that serum components may affect a metabolic pathway of 
interest or disturb the analysis of a metabolite, the cultures should be 
washed twice and subsequently incubated with serum-free culture medium 
for one day before the experiment is started.  
 
 
4. Viability assays 
To confirm that a metabolic study was performed on viable cells it is important 
to assess the biocompatibility of a given treatment or test substance. Two 
methods for testing cell viability following an experimental incubation are 
described here in detail, the quantification of extracellular lactate 
dehydrogenase (LDH) (7) and the staining of cell nuclei with propidium iodide 
(PI) (8). Both assays determine a compromised integrity of the cell membrane. 
Extracellular LDH activity and PI-positive cells are observed only if the cell 
Methods: Publication/Manuscript 1 
 
68 
 
membrane is sufficiently permeabilised to allow release of the cytosolic enzyme 
LDH from the cells and permeation of the fluorescent dye PI into the cells, 
respectively.  
 
 
4.1. Release of lactate dehydrogenase (LDH) from cells 
4.1.1. Principle 
LDH catalyzes the reduction of pyruvate to lactate using NADH as an electron 
donor (Fig. 2A). LDH is localized in high activity in the cytosol of cultured cells. 
Severe damage of the cell membrane during an experimental incubation causes 
a release of this enzyme into the incubation medium. Thus, the extracellular 
activity of LDH can be used as an indicator of the loss in cell membrane 
integrity, while the cellular LDH activity is an indicator for viable cells that 
remained attached to the cell culture dish. LDH activity in incubation media 
and cells is determined by a microtiter plate-based method (7). Pyruvate and 
NADH are added to the LDH-containing sample and the decline in the 
absorbance of NADH at 340 nm is recorded (Fig. 2A). Comparison of the NADH 
generation from media samples with those of completely lysed cells allows 
quantification of the relative activity of released LDH which serves an indicator 
for a loss in cell viability.  
 
 
4.1.2 Materials and solutions 
Materials and equipment: HCl, NaCl, NADH, sodium pyruvate, Triton X-100, 
Tris (tris (hydroxymethyl) aminomethane), 96-well microtiter plates, microtiter 
plate reader with a filter for 340 nm and a kinetic measurement mode. 
 
LDH buffer: Prepare 80 mM Tris-HCl buffer containing 200 mM NaCl (pH 7.2). 
This buffer can be stored at 4?C for a few months. 
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Triton X-100 solution: Prepare a solution containing 1% (w/v) of Triton X-100 
in the incubation medium used for the experiments. This solution can be used 
for a week when stored at 4?C.  
 
LDH reaction mixture: Sufficient amounts of a fresh reaction mixture 
containing 3.6 mM sodium pyruvate and 0.44 mM NADH in LDH buffer should 
be prepared shortly before starting the measurement. 
 
 
4.1.3. Method 
1. For quantification of extracellular or cellular LDH activities following an 
experimental incubation, the initial cellular LDH activity of untreated cells is 
commonly used as a reference. To obtain samples for initial cellular LDH 
activity, untreated cells are washed twice with ice-cold PBS and lysed in an 
appropriate volume of Triton X-100 solution for 30 min at 37°C. The lysis 
volume should be adjusted to the amount of cells to by lysed. For example, 
for APCs and CGNCs in wells of 24-well plates a lysis volume of 200 µL is 
appropriate.  
2. Collect the incubation media after incubation and store them at 4°C until 
determination of LDH activity. If the cellular LDH activity is to be determined 
after incubation, wash the cells twice with ice-cold PBS and lyse them in an 
appropriate volume of Triton X-100 solution for 30 min at 37°C. Collect the 
lysates and store them at 4°C. Do not freeze LDH-containing samples as that 
is likely to damage the enzyme. It is recommended to measure the LDH 
activity of media and cell lysates within 24 h.  
3. Mix 10 µL of samples (media or lysates) with 170 µL LDH buffer in wells of a 
96-well microtiter plate. As controls use 10 µL of cell lysate of untreated 
cells (100% LDH release) and 10 µL of incubation medium that never came 
in contact with cells (0% LDH release). Depending on the LDH activity 
present in lysates or media, the sample volume can be increased to up to 
180 µL at the expense of LDH buffer.  
4. Add 180 µL of the freshly prepared LDH reaction mixture to each well of the 
microtiter plate. Ideally, initiation of the LDH reaction is done by a 
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multichannel dispensing pipette that allows addition of reaction mixture into 
all wells within seconds.  
5. Measure the LDH-dependent decrease in absorbance of NADH at 340 nm 
(Fig. 2B). Calculate the slope from the linear part of the decline in 
absorbance and compare the LDH activity obtained for all samples with 
those obtained for lysates of untreated cells (100% LDH) and medium blanks 
(0% LDH). The extracellular LDH activity determined is proportional to the 
amount of dead cells, while absence of extracellular LDH suggests that the 
cells remained viable during the treatment.  
6. The extracellular LDH activity can be expressed as percent of initial cellular 
LDH activity (= LDHmedium x 100 / LDHuntreated cells) or as percent of the total 
LDH activity for a given time point (= LDHmedium x 100 / (LDHlysate of treated cells + 
LDHmedium of treated cells)). 
 
 
4.1.4. Results and Notes 
1. Fig. 2B shows the time-dependent decline in absorbance at 340 nm for 10 
µL of lysis buffer (IB with 1% Triton X-100) that was never in contact with 
cells or for 10 µL of cell lysates prepared by adding lysis buffer to APCs or 
CGNCs. Only the linear part of the decrease in absorbance (between 1 and 6 
min) should be used to calculate LDH activity in the lysates.  
2. Under certain conditions the extracellular LDH activity cannot be measured 
reliably due to interference of the test compound with the assay and/or 
inhibition of the released LDH by the test compound. To test for such 
interferences, the respective test compound should be added to the Triton X-
100 lysate of untreated cells. Unaltered decline of NADH compared to the 
control (absence of test compound) is a good indication that the test 
compound does not give false negative results when the extracellular LDH 
activity is used as a marker for loss in cell viability. 
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Figure 2: Measurement of lactate dehydrogenase (LDH) activity as a 
parameter for cell viability. A: LDH catalyzes the reduction of pyruvate 
to lactate by using NADH as an electron donor. B: Decline in absorbance 
at 340 nm of a reaction mixture containing 10 µL lysis buffer (1% Triton 
X-100 in IB) or 10 µL lysates of APCs or CGNCs. C,D: Cultured APCs or 
CGNCs were incubated in IB without (con) or with 30 µM CuCl2 (Cu) or 
30 µM AgNO3 (Ag) for 3 h and the extracellular (C) and the cellular (D) 
LDH activities were determined as percent of the initial cellular LDH 
activity. 
 
 
3. To test for the potential toxicity of copper and silver ions to culture brain 
cells, APCs and CGNCs were treated with IB alone (control) or with IB 
containing 30 µM CuCl2 (Cu) or 30 µM AgNO3 (Ag) for 3 h and the cellular 
and extracellular LDH activities were determined. Control cells that had 
been incubated without metal ions showed only a very low extracellular LDH 
activity of less than 10% of the initial cellular LDH activity (Fig. 2C) and the 
cellular LDH activity was only lowered by up to 15% (Fig. 2D), indicating 
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that the incubation conditions hardly harmed the cells. Presence of copper 
or silver ions during the incubation of APCs increased the extracellular LDH 
activity to 13% and 52% of the initial cellular LDH activity, respectively (Fig. 
2C) with a comparable lowering of the cellular LDH activity (Fig. 2D). For 
CGNCs that had been treated with copper or silver ions no increase in 
extracellular LDH activity was observed (Fig. 2C), while the cellular LDH 
activity was lowered by 60% and 70%, respectively (Fig. 2D). The 
discrepancy between the initial cellular LDH activity and the sum of 
extracellular plus cellular LDH activities after treatment may be caused by 
detachment of cells with intact cell membranes, leading to a decrease in 
cellular LDH activities without corresponding increases in extracellular LDH 
activities. To verify this possibility, Triton X-100 can be added to a final 
concentration of 1% to the harvested incubation medium which will lyse 
detached intact cells that are present in the medium and makes their LDH 
detectable. An alternative explanation for the loss in total LDH activity could 
be that LDH released from damaged cells may have become inactivated by 
the metal ions as described before (12,13). 
4. As detection limit for extracellular LDH activity we consider an absorbance 
difference of 0.02 absorbance units obtained within 10 min measurement. 
This value corresponds to 1.29 nmol/min LDH activity in a well of a 
microtitre plate. The detection of LDH in cell lysates depends on the 
investigated cell type. If the cellular LDH activity or the cell density per well 
is very low, the volume of cell lysates applied as sample can be increased. In 
addition, the measurement time of 10 min could be prolonged to increase 
the detection limit. However, for such altered assay conditions the stability 
of the LDH would have to be tested. 
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4.2. Cell permeability for propidium iodide (PI) 
4.2.1. Principle 
The PI staining method visually identifies cells with damaged cell membranes 
that became permeable to PI (8). The fluorescent dye PI (?ex: 535 nm; ?em: 612 
nm) intercalates into DNA (14). Since PI cannot penetrate through an intact cell 
membrane, intact cells are PI-negative while cells with permeabilized 
membranes contain PI-positive nuclei. The membrane permeable fluorescent 
dye Hoechst 33342 (H33342; ?ex: 341 nm; ?em: 461 nm) is applied together with 
PI to visualize all cell nuclei. 
 
 
4.2.2. Materials and solutions 
Materials and equipment: H33342, KH2PO4, K2HPO4, NaCl, PI, 
paraformaldehyde, fluorescence microscope with appropriate excitation and 
emission filters. 
 
Solutions of PI and H33342: Prepare a 1.5 mM PI stock solution and a 1.78 
mM stock solution of H33342 in pure water. These solutions can be stored in 
the dark for several weeks at 4°C. Dilute the stock solutions shortly before 
application to cells in pre-warmed IB to obtain the PI-H33342 solution with 
final concentrations of 5 µM PI and 10 µM H33342 that will be applied to the 
cells.  
 
Paraformaldehyde solution: If the cells are fixed after PI-H33342 staining, a 
solution of 3.5% (w/v) paraformaldehyde in PBS has to be prepared. This 
solution can be stored at -20?C for a month. 
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4.2.3. Method 
1. Wash the cells after the experimental incubation twice with pre-warmed 
(37°C) IB. 
2. Incubate the cells with the PI-H33342 solution (200-500 µL per well of a 24-
well cell culture dish, depending on the cell density) at 37°C for 15 min in 
the dark. 
3. Wash the cells twice with pre-warmed IB and analyse the cells immediately 
for fluorescence under a fluorescence microscope.  
4. If many experimental incubation conditions have to be analysed, it is 
recommended to fix the cells with 3.5% paraformaldehyde in PBS (400 µL 
per well of a 24-well cell culture dish) for 10 min at room temperature.  
5. After paraformaldehyde fixation, wash the cells twice with PBS. The cells can 
then be stored for several hours in the dark at 4°C until analysis of 
fluorescence. 
 
 
4.2.4. Results and Notes  
1. Fig. 3 shows PI-H33342-stainings of APCs and CGNCs that were incubated 
for 3 h without or with 30 µM CuCl2 (Cu) or 30 µM AgNO3 (Ag) in 200 µL IB. 
After 3 h of incubation, the membrane integrity of APCs and CGNCs that 
had been treated without metal ions were not compromised as indicated by 
the absence of any PI-positive cells (Fig. 3A,C), while a high number of cells 
was present in the dishes as indicated by the H33342-staining of all cell 
nuclei (Fig. 3B,D). After treatment with CuCl2, APCs (Fig. 3E), but not 
CGNCs (Fig. 3G) contained a large number of PI-positive cells. In contrast, at 
best, a low number of PI-positive cells were observed for APCs after exposure 
to AgNO3 (Fig. 3I), while CGNCs contained an increased number of PI-
positive cells after such a treatment (Fig. 3K). Thus, the PI-staining suggests 
that under the conditions used the cells in APCs are more vulnerable to Cu2+ 
treatment, whereas cells in CGNCs are preferentially damaged by exposure 
to Ag+ ions. 
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2. It is recommended to include a positive control for each PI/H33342 staining, 
especially if no loss of cell viability is expected for the experimental 
incubations. For APCs and CGNCs, Cu2+ and Ag+ treatments, respectively, 
work well as positive controls. The concentrations of toxic metal ions can be 
increased or lowered depending on the incubation medium and the 
incubation time chosen. As alternative to metal ions, compounds that 
directly interfere with the cell membrane (e.g. treatment with 0.1% Triton-X 
100 for 10 min) can be used to compromise the integrity of the cell 
membrane. 
3. All storage and handling as well as microscopic examinations and 
documentations should be done in the dark to avoid loss of the fluorescent 
signals. 
 
 
Figure 3: Staining of cell nuclei with propidium iodide (PI) and 
Hoechst 33342 (H33342) to assess cell viability. APCs or CGNCs were 
incubated in IB without (con) or with 30 µM CuCl2 (Cu) or 30 µM AgNO3
(Ag) for 3 h. PI-stained nuclei identify cells that have a permeabilized cell 
membrane, while staining with the membrane permeable dye H33342 
identifies the nuclei of all cells present. The scale bar in panel L 
corresponds to 50 µm and applies to all panels. 
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4. It is recommended to document the positive and negative controls first to 
adjust the settings for illumination of PI-positive and H33342-positive cell 
nuclei. These settings should be kept constant for the documentation of the 
stainings of all conditions used in one experiment. 
5. It should be noted that results obtained for cell viability by PI staining (Fig. 
3) may not always be consistent with data obtained by determining 
extracellular LDH activity (Fig. 2).   
 
 
5. Glucose assay 
5.1. Principle 
The microtiter plate-based glucose assay uses the coupled enzymatic reactions 
of hexokinase (HK) and glucose-6-phosphate dehydrogenase (G6PDH) to 
quantify glucose in incubation media (15,16). The glucose in the sample 
solution is phosphorylated by HK to glucose-6-phosphate (G6P) in an ATP and 
Mg2+-dependent reaction. The G6P generated by HK is subsequently oxidized by 
G6PDH to 6-phosphogluconate along with the reduction of NADP+ to NADPH 
(Fig. 4A). The amount of NADPH generated is equimolar to the amount of 
glucose consumed and can be monitored by the increase in absorbance at 340 
nm. 
 
 
5.2. Materials and solutions 
Materials and equipment: ATP, glucose, G6PDH, HK, KOH, MgCl2, NADP+, 
triethanolamine hydrochloride (TEA), 96-well microtiter plates, microtiter plate 
reader with a filter for 340 nm. 
 
Glucose assay buffer: Prepare 0.3 M TEA/KOH buffer (pH 7.6). This buffer can 
be stored at 4?C for up to a few months. Warm the buffer to room temperature 
before use. 
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Glucose reaction mixture: Sufficient amounts of reaction mixture consisting 
of 2.44 U/mL G6PDH, 1.7 U/mL HK, 1.5 mM NADP+, 2 mM ATP and 2 mM 
MgCl2 in glucose assay buffer should be prepared fresh shortly before analyzing 
the glucose contents.  
 
 
5.3. Method 
1. After an experimental incubation, the harvested media samples for glucose 
measurement can be stored at 4?C for a few hours or at -20?C for weeks. 
Dilute 10 µL of media samples in 170 µL pure water in wells of a microtiter 
plate. If the media should contain glucose concentrations higher than 7.5 
mM, dilute the samples appropriately. Use as a negative control (blank) 10 
µL of the incubation medium without glucose (or use pure water if this 
medium is not available) and as a positive control add 10 µL of the glucose-
containing incubation medium which had no contact to cells. 
2. To each well add 180 µL of a freshly prepared glucose reaction mixture and 
incubate the plate at room temperature for 10 min.  
3. Measure the absorbance at 340 nm using a microtiter plate reader and 
convert the absorbance after correction for the blank values to the 
concentration of NADPH generated (in mM) using the Lambert-Beer law with 
a path length of d = 0.9 cm (see note below) and the extinction coefficient of 
???????????????????????????-1cm-1). Alternatively, standards with known 
glucose concentrations may be used to obtain a calibration curve. The value 
calculated should be multiplied by the appropriate dilution factor (the 
dilution factor is 36, if 10 µL of sample was used) to get the glucose 
concentration in the sample. The concentration of glucose consumed by 
cells is calculated by subtracting the medium glucose concentration after 
incubation of cells from the value determined for the medium that was 
applied to the cells.  
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Figure 4: Determination of glucose and glucose consumption. A: 
Glucose is quantified by a coupled enzymatic assay. Hexokinase (HK) 
phosphorylates glucose to glucose-6-phosphate (G6P) which is 
subsequently oxidized by the NADP+-dependent glucose-6-phosphate 
dehydrogenase (G6PDH) to 6-phosphogluconate. B: For 10 µL sample 
volumes of the indicated glucose concentrations in IB the absorbance of 
NADPH at 340 nm increased with time to maximal values within a few 
minutes. C: The absorbance recorded at 340 nm after 10 min increased 
proportionally to the concentration of glucose present. D,E: APCs or 
CGNCs were incubated with 0.2 mL IB (which contains 5 mM glucose). 
Panels D shows the glucose concentration determined for the indicated 
incubation periods and panel E the specific amount of glucose consumed 
by the cells as calculated as protein-normalized difference between the 
glucose applied at the onset of the experiment and the glucose 
determined at the indicated incubation time.  
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5.4. Results and Notes  
1. Fig. 4 shows the increase in absorbance of NADPH at 340 nm as a function 
of time and concentration of glucose (Fig. 4B,C). The absorbance of NADPH 
generated by the coupled HK and G6PDH reactions increased within a few 
minutes to maximal values (Fig. 4B). After 10 min of incubation a linear 
relationship was obtained between the concentration of glucose applied and 
the absorbance at 340 nm (Fig. 4C).  
2. Incubation of APCs and CGNCs in wells of 24-well plates with 200 µL IB 
revealed that the concentration of glucose was lowered during an incubation 
for up to 3 h (Fig. 4D). APCs and CGNCs did not differ substantially in their 
specific glucose consumption (Fig. 4E).  
3. The assay has a detection limit of 0.13 mM glucose in the medium (when 10 
µL of the sample is used). However, by applying higher volumes (up to 180 
µL) media at the expense of the diluting water, the sensitivity of the assay 
can be increased by a factor of up to 18.  
4. The path length of d = 0.9 cm used for calculation of the sample 
concentration by the Lambert-Beer law depends on the geometry of the 96-
well plate used for the measurement as well as on the reaction volume 
within each well. Therefore, the d-value has to be determined for each type 
of 96-well plate, for example by measuring the absorbance of a defined 
volume of a solution with a known concentration of a chromophore (e.g., 
NADH at 340 nm) and subsequent calculation of the d-value by the 
Lambert-Beer law. 
5. It is important to test for the potential interference of a test component with 
the glucose assay. For this purpose, record the NADPH formation in a 
reaction that contains 10 µL of a 5 mM glucose solution in IB as well as the 
test compound in the final concentrations used for the cell experiment and 
compare the results obtained without and with the test component. 
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6.  Lactate assay 
6.1. Principle 
The lactate assay described here has been used to measure the lactate 
concentration in various incubation media (16-18). The enzyme lactate 
dehydrogenase (LDH) catalyzes the oxidation of lactate to pyruvate using NAD+ 
as a co-factor, thereby generating NADH which can be quantified at 340 nm 
(Fig. 5A). Since the equilibrium of the LDH-catalyzed reaction strongly favors 
lactate formation, the lactate oxidation by LDH has to be coupled with another 
reaction to guarantee complete lactate oxidation. The pyruvate generated by 
LDH from lactate is removed by a transamination reaction with glutamate 
catalyzed by the enzyme glutamate pyruvate transaminase (GPT) (Fig. 5A). The 
high concentration of glutamate in the glutamate/NaOH buffer together with 
the alkaline pH of the reaction solution that buffers the protons generated in 
the LDH reaction ensures that the formation of NADH by lactate oxidation is 
maximal (Fig. 5A). Due to the 1:1 stoichiometry between lactate oxidation and 
NADH formation the lactate concentration can by calculated directly by the 
Lambert-Beer law from the absorbance of NADH at 340 nm as described for the 
glucose assay. 
 
 
6.2. Materials and solutions 
Materials and equipment: Glutamic acid, GPT, L-(+)-lactate, LDH, NAD+, 
NaOH, 96-well microtiter plates, microtiter plate reader with a filter for 340 nm. 
 
Lactate assay buffer: Prepare a 0.5 M glutamate/NaOH buffer (pH 8.9). The 
solubility of glutamic acid will improve during adjustment of pH towards the 
alkaline range. This buffer can be stored at 4?C for up to a few months. 
 
Lactate reaction mixture: Prepare sufficient amounts of a fresh reaction 
mixture consisting of 3.89 U/mL GPT, 39.7 U/mL LDH and 5.6 mM NAD+ in 
lactate assay buffer. 
 
Methods: Publication/Manuscript 1 
 
81 
 
6.3. Method 
1. After an experimental incubation, the harvested samples for lactate 
measurement can be stored at 4?C for a few hours or at -20?C for weeks. 
Dilute 10 µL of media samples in 170 µL pure water in a well of a microtiter 
plate. The volume of media samples can be adjusted according to the 
concentration of lactate in the medium. As a negative control (blank) use 10 
µL of the incubation medium that had no contact to cells, whereas for a 
positive control for complete oxidation of lactate use 10 µL of a 5 mM lactate 
solution in IB.  
2. To each well add 180 µL of a freshly prepared lactate reaction mixture and 
incubate the plate in a humidified atmosphere of a CO2-free cell incubator at 
37?C for 90 min.  
3. Measure the absorbance at 340 nm using a microtiter plate reader and 
convert the absorbance after correction for the blank values to the 
concentration of NADH as described above for the glucose assay. 
Alternatively, standards with known lactate concentrations may be used to 
obtain a calibration curve. Use the appropriate dilution factors to calculate 
the concentration of lactate in the samples.  
 
 
6.4. Results and Notes  
1. Fig. 5B shows the increase in absorbance of NADH at 340 nm as a function 
of time and concentration of lactate. The absorbance of NADH generated by 
the LDH reaction increased within 90 min to maximal values (Fig. 5B). After 
90 min of incubation a linear relationship was obtained between the 
concentration of lactate applied and the absorbance at 340 nm (Fig. 5C). 
2. Incubation of APCs and CGNCs in wells of 24-well plates in 200 µL IB (which 
contains 5 mM glucose) for up to 3 h caused a strong increase in the 
extracellular lactate concentrations (Fig. 5D). The specific lactate release of 
APCs was almost doubled compared to that determined for CGNCs (Fig. 5E). 
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Figure 5: Determination of lactate and lactate production. A: Lactate 
is quantified by a coupled enzymatic assay. Lactate dehydrogenase (LDH) 
oxidizes lactate to pyruvate, thereby reducing NAD+ to NADH. To 
establish complete oxidation of lactate, the pyruvate formed in the LDH 
reaction is transaminated by glutamate pyruvate transaminase (GPT) to 
alanine in presence of a large excess of glutamate. The high pH of the 
reaction buffer (pH 8.9) buffers the proton generated during lactate 
oxidation, thereby also supporting the complete oxidation of lactate. B: 
For 10 µL sample volumes of the indicated lactate stock solutions in IB 
the absorbance of NADH at 340 nm increased with time to a maximal 
value after 90 min. C: The absorbance recorded after 90 min at 340 nm 
increased proportionally to the concentration of lactate present. D,E: 
APCs or CGNCs were incubated with 0.2 mL IB (which contains 5 mM 
glucose). Panel D shows the extracellular lactate concentration 
determined for the indicated incubation periods and panel E the specific 
amount of lactate produced by the cells. 
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3. For 10 µL of medium sample the assay has a detection limit for lactate of 
about 0.13 mM. However, by applying higher volumes (up to 180 µL) media 
at the expense of the water, the sensitivity of the assay can be increased by a 
factor of 18.  
4. Alternatively to the photometric quantification of the NADH generated, the 
amount of NADH produced by the assay reaction can also be measured by 
fluorescence (excitation 340 nm, emission 460 nm) which allows an even 
higher sensitivity and a lower detection limit for lactate. For this 
fluorescence method, the use of a lactate calibration curve is required. 
5. It is important to test for the potential interference of a test component with 
the lactate assay. For this purpose, record the NADH formation in a reaction 
that contains 10 µL of a 5 mM lactate solution in IB as well as the test 
compound in the final concentrations used for the cell experiment and 
compare the results obtained for the conditions without and with the test 
component. 
 
 
7. Glutathione (GSH) assay 
7.1. Principle 
The enzymatic cycling method for quantification of glutathione (GSH) has 
originally been described by Tietze (19) and was modified for the use of 
microtiter plates (20-22). The underlying mechanism of this assay is the 
reduction of 5,5’-dithio-bis(2-nitrobenzoic acid) (DTNB) by GSH to form 5-thio-
2-nitrobenzoate (TNB) that can be monitored at 405 nm (Fig. 6A). The 
glutathione disulfide (GSSG) formed during this reaction is reduced to GSH by 
the NADPH-dependent glutathione reductase (GR). Thus, the GSH and the 
GSSG present in a sample are continuously cycled by DTNB-mediated oxidation 
and GR-catalysed reduction, thereby leading to a signal amplification by the 
continuous formation of TNB. The rate of TNB formation depends exclusively on 
the total amounts of GSH and GSSG in the sample. Thus, this method 
determines in its basal version the amount of total glutathione (GSx = amount 
of GSH plus twice the amount of GSSG) in a sample. The assay is highly 
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specific for the detection of GSH and GSSG due to the high substrate specificity 
of GR for GSSG. The slope of the increase in absorbance at 405 nm per minute 
correlates to the GSx content in the sample and can be quantified by 
comparison to that of GSx standards. To discriminate between GSH and GSSG, 
2-vinylpyridine (2VP) can be added to the sample which masks GSH by the 
formation of a GSH-2VP conjugate that cannot be detected by this assay. As 
GSSG does not react with 2VP (23), all remaining GSx that is detectable after 
derivatization of a sample with 2VP represents GSSG. 
 
 
7.2. Materials and solutions 
Materials and equipment: DTNB, ethylenediamine tetraacetic acid (EDTA), GR, 
GSSG, NADPH, NaH2PO4, Na2HPO4, sulfosalicylic acid (SSA), Tris base (Tris), 
2VP, 96-well microtiter plates, microtiter plate reader with a filter for 405 nm 
and a kinetic measurement mode. 
 
GSx assay buffer: Prepare a 0.1 M sodium phosphate buffer containing 1 mM 
EDTA, pH 7.5. This solution can be stored at 4?C for a few months. 
 
SSA solution: Prepare a 1% (w/v) SSA solution in pure water. This solution is 
stable for a few months when stored at 4?C. 
 
GSx standards: Prepare standard concentrations of GSSG in 1% SSA solution 
in duplicates ranging from 0 to 50 pmol/10 µL. These standards correspond to 
GSx concentrations of 0 to 100 pmol/10 µL (0-10 µM). The GSx standards can 
be used for weeks, if stored at 4?C. 
 
Tris solution: Prepare a solution of 0.2 M Tris in pure water. This solution can 
be stored at 4?C for a few months. 
 
GSx reaction mixture: Directly before application to the GSx-containing 
samples in wells of a microtiter plate, prepare sufficient amounts of a fresh 
reaction mixture containing 0.6 U/mL GR, 400 µM NADPH and 400 µM DTNB 
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in GSx assay buffer. It is important to prepare this mixture just prior to 
addition to the samples in the 96-well plate as a slow chemical reaction will 
result in the formation of TNB within this reaction mixture, even in the absence 
of GSx. 
 
 
7.3. Method for GSx quantification  
1. For analysis of GSx content in media samples, collect media samples and 
immediately mix the samples with an identical volume of ice-cold 1% SSA. 
Store the sample at 4°C till measurement. For analysis of cellular GSx 
contents, wash the cells with ice-cold PBS as previously described (chapter 
3), remove the residual washing fluid and immediately add 200 µL of ice-cold 
1% SSA to each well of a 24-well plate. Lyse the cells at 4?C for 10 min. 
Transfer the lysates to cups, spin them at 12,000 g for 1 min and store the 
supernatant at 4°C until GSx quantification. 
2. Dilute 20 µL of the SSA-diluted media samples or 10 µL of the cell lysates 
with water in wells of a microtiter plate to a total volume of 100 µL. 
Similarly, dilute 10 µL of GSx standards with 90 µL of water in wells of the 
microtiter plate. 
3. Prepare a fresh GSx reaction mixture and add 100 µL of this reaction 
mixture to each well of the microtiter plate. This should be done by a 
multichannel dispensing pipettor that allows adding of reaction mixture 
into all wells within seconds. 
4. Monitor the increase in absorbance at 405 nm over 10 min at 30 s 
intervals. Compare the slopes in absorbance recorded for the samples with 
those of the standards and calculate the amount of GSx in the samples. 
 
 
7.4. Method for GSSG quantification 
1. For analysis of the GSSG content of cell lysates or media samples, it is 
necessary to conjugate the GSH with 2VP. For quantification of GSSG in cell 
lysates, transfer 130 µL of the centrifuged cell lysates or 130 µL GSx 
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standards into fresh sample cups. For GSSG quantification in media, 
transfer 130 µL of SSA-diluted media samples or 130 µL GSx standards that 
had been diluted 1:1 with the incubation medium into fresh cups.  
2. Add 5 µL of 2VP to each cup under a proper safety hood as 2VP is highly 
toxic. Adjust the pH with an appropriate volume of 0.2 M Tris solution to 
around pH 6. Mix the samples well directly after addition of the Tris solution 
and incubate at room temperature for 1 h. 
3. Dilute 10 µL of each derivatization reaction for cell lysates (or their 
standards) and 20 µL of derivatized media samples (or their standards) with 
water in wells of a microtiter plate to a total volume of 100 µL. 
4. Prepare a fresh GSx reaction mixture and add 100 µL of this reaction 
mixture to each well of the microtiter plate. This should be done by a 
multichannel dispenser pipette that allows adding of reaction mixture into 
all wells within seconds. 
5. Monitor the increase in absorbance at 405 nm over 10 min at 30 s intervals. 
Compare the slopes in absorbance recorded for the samples with those of 
the standards and calculate the amount of GSSG (given as GSx) in the 
samples. 
 
 
7.5. Results and Notes  
1. Fig. 6B shows the time-dependent increase in absorbance at 405 nm for 8 
different concentrations of GSx standards. The slopes calculated from the 
linear increases in absorbance with time are proportional to the 
concentration of GSx applied to the cycling reactions (Fig. 6C).  
2. Incubation of cultured brain cells in wells of 24-well plates in 200 µL IB 
caused a substantial decrease in cellular GSx content of APCs within 3 h, 
but only a mild loss of cellular GSx from CGNCs (Fig. 6D). The cellular loss 
of GSx in APCs was accompanied by the appearance of substantial amounts 
of GSx in the incubation medium, while only low amounts of GSx were 
detected in the media of CGNCs (Fig. 6E).  
3. Use a fresh tip for each pipetting of 1% SSA to guarantee the application of 
identical volumes of the SSA solution. 
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Figure 6: Determination of total glutathione (GSx = amount of GSH 
plus twice the amount GSSG). A: GSx is quantified by a highly sensitive 
enzymatic cycling assay. Two molecules of GSH reduce the disulfide 
dithionitrobenzoate (DTNB) to 2 molecules of thionitrobenzoate (TNB). 
The GSSG generated from GSH in this reaction as well as GSSG that was 
already present in the sample is subsequently reduced to GSH by 
glutathione reductase (GR) which uses NADPH as electron donor. This 
GSH starts a new cycle of DTNB reduction and enzymatic GSH 
regeneration. The increase in absorbance of TNB over time at 405 nm is 
proportional to the amount of GSx present in the reaction. B: Increase in 
absorbance at 405 nm for 10 µL samples of the indicated concentrations 
of GSx in the reactions. C: The slope of the linear increase in absorbance 
of TNB with time (calculated from the data presented in B) is proportional 
to the concentration of GSx cycling within the reactions. D,E: APCs or 
CGNCs were incubated with 0.2 mL IB. Under those conditions, the cell 
viability was not compromised (data not shown). Panel D shows the 
specific cellular GSx contents and panel E the specific amount of 
extracellular GSx determined for the indicated incubation periods. 
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4. The contents of GSx and GSSG in media or cell lysates should be measured 
within hours after collecting the media samples and preparing the cell 
lysates as the amount of detectable GSx is already lowered within 1 d of 
storage even at temperatures of -80°C or -20°C. 
5. The detection limit for GSx in the assay described here is 0.2 nmol in 0.2 mL 
lysate or media samples. 
6. The 2VP used for derivatization of GSH is highly toxic and has a repulsive 
odor. Handle all samples under a fume hood and dispose all liquids as well 
as the microtiter plate used into toxic waste.  
7. For each combination of Tris solution and 1% SSA solution (or SSA solution 
diluted with media) test in advance how much of the Tris solution has to be 
added to adjust the pH to around pH 6 (tolerable range 5.5 to 6.5). 
8. Specific values for GSx contents of cultured cells strongly depend on the 
culturing conditions, the age of the cultures, the availability of GSH 
precursors and the consumption of cellular GSH for export and 
detoxification reactions. In addition, even for cultures that had been 
prepared following the same protocol, the specific values for the GSx 
contents of untreated cultures may strongly differ, in extreme cases by a 
factor of up to 2. 
 
 
8. Concluding remarks  
In this chapter, we present methods to prepare cultures that are highly 
enriched in astrocytes or cerebellar granule neurons as well as several methods 
that have been successfully used to determine the glucose and GSH metabolism 
of these cells. However, astrocyte- and neuron-rich cultures have also been 
used to investigate other metabolic pathways of brain cells, for example the 
glycogen metabolism (17,24,25), the glutamate metabolism (26), the 
NAD+/NADH redox state (27,28), the formation of nitric oxide (29) and many 
more. In addition, such cultures have also been used to study the activity of cell 
type-specific enzymes involved in brain energy metabolism (9,30). The methods 
described here in detail are useful for studies of the metabolism of cultured 
astrocytes and neurons. However, by small adaptations especially concerning 
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incubation and sample volumes, the methods described here can also be used 
for the investigation of the metabolism of other types of cultured cells, for 
example that of cultured oligodendrocytes or microglial cells (31).  
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Abstract 
Formaldehyde is endogenously produced in the human body and brain levels of 
this compound are elevated in neurodegenerative conditions. Although the toxic 
potential of an excess of formaldehyde has been studied, little is known on the 
molecular mechanisms underlying its neurotoxicity as well as on the ability of 
neurons to metabolize formaldehyde. To address these topics we have used 
cerebellar granule neuron cultures as model system. These cultures express 
mRNAs of various enzymes that are involved in formaldehyde metabolism and 
were remarkably resistant towards acute formaldehyde toxicity. Cerebellar 
granule neurons metabolized formaldehyde with a rate of around 200 nmol/(h x 
mg) which was accompanied by significant increases in the cellular and 
extracellular concentrations of formate. In addition, formaldehyde application 
almost doubled the rate of lactate release from viable neurons and strongly 
accelerated the export of the antioxidant glutathione. The latter process was 
completely prevented by inhibition of the known glutathione exporter multidrug 
resistance protein 1. These data indicate that cerebellar granule neurons are 
capable of metabolizing formaldehyde and that the neuronal glucose and 
glutathione metabolism is severely affected by the presence of formaldehyde.  
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Introduction 
Formaldehyde is the simplest aldehyde that shows high reactivity towards 
cellular macromolecules like DNA and proteins (Lu et al. 2010, Ospina et al. 
2011). Formaldehyde is not only ubiquitously present as an environment 
pollutant (de Groot et al. 2009, Dhareshwar and Stella 2008), but is also 
generated in substantial amounts in the human body by enzyme-catalyzed 
reactions (Cloos et al. 2008, Hou and Yu 2010, O’Sullivan et al. 2004). However, 
owing to formaldehyde detoxification by cellular enzymes (MacAllister et al. 
2011, Friedenson 2011), a steady state balance between formaldehyde-
generating and -disposing processes is established that leads to a normal blood 
formaldehyde concentration of around 0.1 mM (Heck and Casanova 2004). 
Formaldehyde-generating processes include methanol oxidation, methylamine 
deamination and histone demethylation (Cloos et al. 2008, Hou and Yu 2010, 
Lee et al. 2008, O’Sullivan et al. 2004), while formaldehyde disposal occurs 
either by reduction to methanol via the cytosolic alcohol dehydrogenase (ADH) 1 
(MacAllister et al. 2011, Friedenson 2011) or by oxidation to formate (Fig. 1). 
Formaldehyde oxidation is catalyzed by cytosolic ADH3 or by mitochondrial 
aldehyde dehydrogenase (ALDH) 2 (Friedenson 2011, MacAllister et al. 2011). 
While ALDH2 acts directly on formaldehyde, the substrate for ADH3 is a 
formaldehyde-glutathione (GSH) adduct that is formed in an enzyme-
independent reaction (MacAllister et al. 2011, Staab et al. 2009, Thompson et 
al. 2010). The formaldehyde-derived formate can either be exported from the 
cells via gamma-amino butyric acid receptors (Mason et al. 1990) and the 
monocarboxylate transporter 1 (Moschen et al. 2012) or can undergo further 
oxidation to CO2 (Fig. 1). Formate oxidation is a tetrahydrofolate (THF)-
dependent two-step process where formate first reacts with THF to form 10-
formyl THF in an ATP-dependent enzymatic reaction catalyzed by the cytosolic 
methylene THF dehydrogenase (MTHFD) 1 or by the mitochondrial MTHFD1L 
(Krupenko et al. 2010, Krupenko 2009) (Fig. 1). Subsequently, the cytosolic 
ALDH1L1 or its mitochondrial isoform ALDH1L2 oxidize 10-formyl THF to 
generate carbon dioxide (Krupenko et al. 2010, Krupenko 2009) (Fig. 1). To a 
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lesser extent, catalase can also contribute to formate oxidation in a THF-
independent manner (Skrzydlewska 2003).  
The concentration of formaldehyde in the healthy human brain has been 
reported to be around 0.2 mM and 0.4 mM in the hippocampus and cortex, 
respectively (Tong et al. 2012). However, formaldehyde levels in the brain have 
been shown to increase even further with age and in Alzheimer´s disease (AD) 
(Tong et al. 2012, Tong et al. 2011). The reason for these increases in 
formaldehyde concentrations could be the elevated expression of formaldehyde-
generating enzymes, as reported for the methylamine deaminating 
semicarbazide-sensitive amine oxidase (SSAO) in AD (del Mar Hernandez et al. 
2005, Ferrer et al. 2002, Unzeta et al. 2007).  Moreover, during ageing increased 
activity of carboxymethyl esterase, an enzyme generating methanol by 
demethylation of post-translationally modified proteins, has been observed in 
the brain (Sellinger et al. 1988) which may foster elevated formation of 
formaldehyde by providing the substrate for methanol oxidation. 
Animal studies have demonstrated that formaldehyde has toxic effects on the 
nervous system, causes oxidative damage to the brain and compromises 
memory and learning (Songur et al. 2010, Tong et al. 2012, Tong et al. 2011). 
However, there is limited information on the formaldehyde metabolism in brain 
cells and on the molecular mechanisms underlying its neurotoxicity. Recently 
we have shown that cultured astrocytes efficiently oxidize formaldehyde to 
formate and that formaldehyde exposure accelerates glycolytic flux and GSH 
export from glial cells (Tulpule and Dringen 2012, Tulpule and Dringen 2011, 
Tulpule et al. 2012). Here we show that also primary cerebellar granule neurons 
have the potential to oxidize formaldehyde and that presence of formaldehyde 
accelerates lactate production and multidrug resistance protein (Mrp) 1-
mediated GSH export from viable neurons.  
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Materials and Methods 
Materials 
Fetal calf serum and penicillin/streptomycin solution were purchased from 
Biochrom (Berlin, Germany), minimal essential medium from Gibco Life 
Technologies (Darmstadt, Germany) and Earle´s balanced salt solution from Life 
Technologies-Invitrogen (Darmstadt, Germany). Cytosine ?-D-
arabinofuranoside, poly-D-lysine and soybean trypsin inhibitor were obtained 
from Sigma-Aldrich (Steinheim, Germany). Formaldehyde was purchased from 
Merck (Darmstadt, Germany). Bovine serum albumin (BSA), NAD+, NADH and 
NADPH were from Applichem (Darmstadt, Germany). The enzymes glutamate 
pyruvate transaminase, glutathione reductase and lactate dehydrogenase (LDH) 
were from Roche (Mannheim, Germany), while formaldehyde dehydrogenase 
and formate dehydrogenase were from Sigma-Aldrich (Steinheim, Germany). 
Primers for RT-PCRs were purchased from MWG Biotech (Ebersberg, Germany), 
RedSafe™ from HiSS Diagnostics (Freiburg, Germany) and the RNeasy® Mini 
Kit from Qiagen (Hilden, Germany). Deoxyribonucleoside triphosphate (dNTP) 
mix, DNA loading dye, GeneRuler™, 50 bp DNA ladder, RevertAid™ H Minus 
First Strand cDNA Synthesis Kit, magnesium chloride, Taq buffer and Taq 
polymerase were purchased from Fermentas (St. Leon-Rot, Germany). Other 
chemicals of the highest purity available were from Fluka (Buchs, Switzerland) 
or Merck (Darmstadt, Germany).  96-well microtitre plates (transparent and 
black) and 24-well plates were from Nunc (Wiesbaden, Germany).  
 
 
Cell cultures 
Cerebellar granule neuron-rich cultures were prepared from the brains of 7-8 
day old Wistar rats according to a method described by Anggono et al. (2008). 
Briefly, the cerebellae were dissected and a single cell suspension was produced 
by tryptic digestion with 2.5% (w/v) trypsin in phosphate buffered saline (PBS; 
10 mM potassium phosphate buffer, pH 7.4, containing 150 mM NaCl) 
containing 14 mM glucose, 60 mM MgSO4 and 0.3% (w/v) BSA followed by 
manual trituration with glass pipettes. In wells of poly-D-lysine coated 24-well 
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dishes, 0.75 million cells were seeded in 1 mL of culture medium (90% minimal 
essential medium, 10% heat-inactived fetal calf serum, 30 mM D-glucose, 25 
mM KCl, 2 mM L-glutamine, 200 U/L penicillin G and 200 µg/L streptomycin 
sulfate). The cells were cultured at 37°C in a humidified atmosphere with 5% 
CO2 in a cell incubator (Sanyo, Osaka, Japan). After one day in culture the 
medium was replaced by culture medium containing 10 µM cytosine ?-D-
arabinofuranoside. The cells were used for experiments at a culture age 
between 7 and 10 days. 
Astrocyte-rich primary cultures were prepared from the brains of newborn 
Wistar rats (Hamprecht and Löffler 1985). Cells were seeded in culture medium 
in 24-well plates (0.3 million cells per 1 mL) and incubated in the humidified 
atmosphere of a Sanyo (Osaka, Japan) incubator with 10% CO2. The culture 
medium was renewed every seventh day and the cultures were used for 
experiments at an age between 15 and 21 days.  
 
 
Experimental incubation of cells  
If not stated otherwise, cultured neurons were washed with 1 mL pre-warmed 
(37ºC) incubation buffer (IB; 145 mM NaCl, 30.4 mM KCl, 1.8 mM CaCl2, 1 mM 
MgCl2, 0.8 mM Na2HPO4, 20 mM HEPES, 5 mM glucose, pH 7.4) and exposed to 
formaldehyde in 200 µL IB containing formaldehyde and/or other compounds 
at 37ºC. For incubations at 4ºC, cells were washed with ice-cold (4ºC) IB and 
incubated with 200 µL formaldehyde-containing IB at 4°C. The experimental 
incubations were terminated by collecting the incubation media and by washing 
the cells with 1 mL of ice-cold PBS. For experiments investigating the 
requirement of formaldehyde for the stimulated GSH export, the pre-incubation 
medium was aspirated, cells were washed once with 1 mL pre-warmed (37ºC) IB 
and incubated further with 200 µL IB containing the indicated compounds. At 1 
h intervals, 10 µL media samples were harvested to determine total glutathione 
(GSx) contents. 
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Determination of cell viability and protein content 
Release of the cytosolic enzyme LDH and the membrane permeability for the 
fluorescent dye propidium iodide (PI) were assessed to determine compromised 
cell viability. LDH activity in cell lysates and media was measured using a 
microtitre plate-based photometric assay (Dringen et al. 1998). As a 
modification, some media samples were treated with Triton X-100 (final 
concentration of 0.5% (v/v)) to lyse potentially detached cells with intact cell 
membranes. PI staining of the cells was performed as previously described 
(Scheiber et al. 2010). The protein content of the cultured cells was determined 
after lysing of the cells with 200 µL 0.5 M NaOH by the Lowry method (Lowry et 
al. 1951), using BSA as a standard protein. The neuron cultures contained an 
average protein content of 51 ± 10 µg per well. 
 
 
Determination of formaldehyde, formate, lactate and glutathione 
The concentrations of formaldehyde, formate and lactate were determined by 
enzymatic assay systems as recently described (Liddell et al. 2009, Schmidt and 
Dringen 2009, Tulpule and Dringen 2012). Total glutathione contents (GSx = 
amount of GSH plus twice the amount of glutathione disulfide (GSSG)) and 
GSSG contents in cells and media were determined by the colorimetric Tietze 
cycling assay in microtitre plates (Hirrlinger and Dringen 2005). 
 
 
Reverse transcription polymerase chain reaction (RT-PCR) analysis 
Cells seeded in 24-well plates were used for extraction of total RNA. The 
RNeasy® Mini Kit and the RevertAid™ H Minus First Strand cDNA Synthesis Kit 
were used for extraction of RNA and its reverse transcription for synthesis of 
cDNA following the instructions provided by the supplier. PCRs were performed 
as previously described (Tulpule et al. 2010) using the primer sets and 
annealing temperatures listed in Table 1. Gel electrophoresis was performed in 
a 2.5% agarose gel containing 1x RedSafe™. 
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Presentation of data  
Data are presented as means ± SD of values that were obtained in n 
experiments (given in the panels of the figures) performed on independently 
generated cultures. Pictures showing PI stainings or RT-PCRs were taken from 
representative experiments that were reproduced at least twice with comparable 
outcomes. The analysis of significance between groups of data was performed 
by ANOVA followed by the Bonferroni post-hoc tests with *p<0.05, **p<0.01 and 
***p<0.001. Significance of differences between 2 data sets was analyzed with 
the paired t-test and is indicated by #p<0.05, ##p<0.01 or ###p<0.001. p>0.05 
was considered as not significant. 
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Results 
Viability of cultured neurons after exposure to formaldehyde 
To test for potential neurotoxic effects of formaldehyde, cultured cerebellar 
granule neurons were incubated with formaldehyde in concentrations of up to 1 
mM for up to 6 h (Fig. 2). Exposure of the cells to formaldehyde for 2 h did not 
significantly elevate the activity of LDH in the medium compared to controls, 
irrespective of whether the medium was treated with Triton X-100 or not (Fig. 
2A). Accordingly, only a low number of PI-positive cells were found after a 2 h 
treatment without or with formaldehyde in concentrations of up to 1 mM (Fig. 
2I-L). In contrast, all neurons in cultures that had been treated with 100 µM 
silver nitrate for 2 h or 6 h (positive control for toxicity) were PI-positive (Fig. 
2H,M,R,W). Also, an incubation of neurons for 6 h with 0.1 mM formaldehyde 
did not compromise cell viability (Fig. 2B,C,T), while exposure of the cells to 0.5 
mM or 1 mM formaldehyde caused a small but significant increase in the LDH 
activity in Triton X-100-treated media (Fig. 2B) and a matching loss in cellular 
LDH activity (Fig. 2C). However, exposure of the cells to 0.5 mM or 1 mM 
formaldehyde did not severely increase the number of PI-positive neurons (Fig. 
2U,V), suggesting that the membranes of the cells that remained attached to 
the well under those conditions were intact.  
 
 
Formaldehyde clearance by neurons 
The observed resistance of neurons to formaldehyde toxicity could be associated 
with their capacity to metabolize the applied formaldehyde. RT-PCRs were 
performed to test for expression in cerebellar granule neuron cultures (as well 
as in astrocyte primary cultures as control cells) of the enzymes involved in 
formaldehyde metabolism (Fig. 1). Indeed, bands of the expected sizes (Table 1) 
were observed for mRNAs of formaldehyde-metabolizing enzymes for both cell 
culture types (Fig. 3), suggesting that neurons may indeed have the capacity to 
reduce formaldehyde to methanol and/or to oxidize formaldehyde via formate to 
CO2 (Fig. 1). Among the investigated enzymes, at best a very weak signal was 
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observed for the mRNA of ALDH1L1 in cultured neurons, while this band was 
clearly detectable for astrocyte cultures (Fig. 3). 
To test whether neurons are indeed able to oxidize formaldehyde, cerebellar 
granule neurons were exposed to 0.5 mM formaldehyde for up to 3 h and 
formaldehyde and formate concentrations were determined in the media (Fig. 
4A, circles). A control incubation without cells but otherwise under identical 
conditions revealed that hardly any formaldehyde was lost from the medium by 
evaporation or cell-independent oxidation to formate (Fig. 4A, triangles). In 
contrast, a decline in the extracellular formaldehyde concentration and an 
increase in the concentration of formate in the medium were observed on 
incubation of neurons with formaldehyde (Fig. 4A). The linear changes in the 
concentrations of formaldehyde and formate in the medium were used to 
calculate formaldehyde clearance and formate release rates of 210 ± 24 nmol/(h 
x mg) and 51 ± 10 nmol/(h x mg), respectively (Fig. 4B). Treatment of neurons 
with 0.5 mM formaldehyde for 2 h also increased the cellular level of formate 
significantly from a basal level of 4 ± 3 nmol/mg to 17 ± 3 nmol/mg (Fig. 4C). 
Under these conditions a reduction of formaldehyde is unlikely to contribute to 
the disappearance of formaldehyde, since no increase in the concentration of 
extracellular methanol was observed (data not shown).  
Formaldehyde forms adducts with cellular macromolecules like proteins and 
DNA (Ospina et al. 2011, Lu et al. 2010). Such processes could contribute to 
the decline in detectable formaldehyde observed for cultured neurons. To 
differentiate between a chemical reaction of formaldehyde with macromolecules 
and metabolic formaldehyde oxidation, the cells were incubated with 0.5 mM 
formaldehyde for 2 h at 37?C or 4?C, as the low temperature is known to 
completely prevent cellular formaldehyde metabolism but not its chemical 
reactivity (Tulpule and Dringen 2012). Formate was not detectable in the 
medium of cells that had been exposed to formaldehyde at 4°C (Fig. 4D), while 
the disappearance of formaldehyde was lowered by around 50% compared to 
cells that had been exposed to the aldehyde at 37°C (Fig. 4D). The cell viability 
was not affected by incubation of cells with formaldehyde at these temperatures 
(data not shown).  
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Effect of formaldehyde exposure on lactate production by neurons 
Formate accumulating within cells has the potential to affect ATP production as 
formate inhibits cytochrome c oxidase (Wallace et al. 1997, Nicholls 1975) 
which in turn may stimulate glycolysis (Walz and Mukerji 1988). To test 
whether exposure of neurons to formaldehyde affects cellular glucose 
metabolism, cerebellar granule neurons were treated with formaldehyde in a 
concentration of 0.5 mM. Already after 15 min of incubation a significantly 
elevated extracellular lactate concentration was determined for formaldehyde-
treated cells compared to control neurons (Fig. 5A). Calculation of the lactate 
release rates (Fig. 5B) from the linear increase in extracellular lactate contents 
revealed that presence of formaldehyde almost doubled the lactate release rate 
compared to control cells from 0.89 ± 0.16 to 1.57 ± 0.27 µmol/(h x mg) (Fig. 
5B). 
 
 
GSH export from formaldehyde-treated neurons 
Formaldehyde treatment has been reported to stimulate GSH export from glial 
cells (Tulpule and Dringen 2011, Tulpule et al. 2012). Similarly, the application 
of formaldehyde to neurons caused a time- and concentration-dependent 
increase in extracellular GSx content (Fig. 6A,D) that was accompanied by a 
matching decline in cellular GSx contents (Fig. 6B,E), while the sum of cellular 
plus extracellular GSx remained almost constant for all the conditions used 
(Fig. 6C,F). In the absence of formaldehyde, cultured neurons exported, at best, 
low amounts of GSH while upon application of formaldehyde a rapid 
extracellular GSx accumulation was observed for the first 2 h of incubation 
which slowed down thereafter (Fig. 6A). Half-maximal effects on the cellular and 
extracellular GSx contents of neurons after incubation for 2 h were found for 
around 0.3 mM formaldehyde, while presence of 1 mM formaldehyde induced 
maximal effects (Fig. 6D,E). 
Formaldehyde-accelerated GSH export from glial cells is mediated by Mrp1 
(Tulpule and Dringen 2011, Tulpule et al. 2012). Mrp 1 transports anionic 
compounds such as GSH and conjugates of GSH in an ATP-dependent manner 
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(Keppler 2011). Since cultured neurons contain Mrp1 mRNA (data not shown), 
Mrp1 was considered as a potential transporter to mediate formaldehyde-
induced GSH export from neurons. Indeed, presence of the Mrp1 inhibitor 
MK571 (Hirrlinger et al. 2002, Minich et al. 2006) almost completely prevented 
the formaldehyde-induced extracellular accumulation of GSx (Fig. 7A) and the 
corresponding cellular decline of GSx (Fig. 7B), while the sum of cellular plus 
extracellular GSx was not affected by the absence or presence of formaldehyde 
and/or MK571 (Fig. 7C). Quantification of GSSG content which contributes to 
the determined GSx amounts revealed that the very low GSSG levels in 
cerebellar granule neurons or their media were not increased after exposure of 
the cells to formaldehyde and/or MK571 (Fig. 7). None of these conditions 
compromised the cell viability as indicated by the absence of any significant 
increase in extracellular LDH activity (data not shown).   
To investigate whether the formaldehyde-induced GSH export depends on the 
presence of formaldehyde, neurons were pre-incubated without or with 0.5 mM 
formaldehyde for 1 h after which the cells were exposed to fresh medium 
containing no or 0.5 mM formaldehyde (Fig. 8). The accelerated GSH export was 
only maintained by cells that were exposed to formaldehyde during the main 
incubation (Fig. 8A, filled triangles), while removal of formaldehyde (Fig. 8A, 
open triangles) slowed the further increase of extracellular GSx contents to 
values that were comparable to those of control cells that had no contact to 
formaldehyde (Fig. 8, circles). This is also reflected by the export rates 
calculated for the main incubation (Fig. 8B). The GSH export of cells that had 
been exposed to formaldehyde only during the pre-incubation did not 
significantly differ from the values determined for cells that had no contact with 
formaldehyde (about 1.5 nmol/(h x mg)), while the presence of 0.5 mM 
formaldehyde during the main incubation increased the GSH efflux rate by 
three-fold (Fig. 8B).  
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Figure 1: Formaldehyde metabolism. Formaldehyde can be reduced to 
methanol by alcohol dehydrogenase (ADH) 1 or oxidized to formate by 
cytosolic (cyt) glutathione (GSH)-dependent ADH 3 or by the 
mitochondrial (mito) aldehyde dehydrogenase (ALDH) 2. Further 
oxidation of formate to CO2 involves the formation of 10-formyl 
tetrahydrofolate (THF) by the cytosolic methylene tetrahydrofolate 
dehydrogenase (MTHFD) 1 or the mitochondrial MTHFD1L and the 
subsequent oxidation of 10-formyl THF by the cytosolic 10-formyl THF 
dehydrogenase ALDH1L1 or the mitochondrial ALDH1L2 to CO2.  
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Figure 2: Formaldehyde toxicity in cultured neurons. Cells were 
incubated with the indicated concentrations of formaldehyde for up to 6 
h. LDH activity in untreated or Triton X-100-treated media was 
determined after 2 h (A) or 6 h (B) while that in cells (C) was measured 
after 6 h of incubation. The nuclei of cells that had been treated for 2 h 
or 6 h with formaldehyde in the indicated concentrations (D-G, I-L, N-Q, 
S-V) or with 100 µM AgNO3 (positive control, H,M,R,W) were stained with 
Hoechst 33342 (D-H, N-R), while those of cells with impaired membrane 
integrity were positive for propidium iodide (PI) staining (I-M, S-W). The 
scale bar in panel I applies to the panels D-W. In A-C, the significance of 
differences compared to controls (ANOVA) is indicated by *p<0.05 or 
**p<0.01 while that between treatment of media samples with or without 
Triton X-100 (paired t-test) is indicated by #p<0.05. 
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Figure 3: RT-PCR analysis of expression of enzymes involved in 
formaldehyde and formate metabolism. mRNAs harvested from 
cerebellar granule neurons culture (CGNC) or astrocyte-rich primary 
culture (APC) were used as source to generate specific amplification 
products that demonstrate the presence of mRNAs of the indicated 
alcohol dehydrogenases (ADH), aldehyde dehydrogenases (ALDH) or 
methylene tetrahydrofolate dehydrogenases (MTHFD). 
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Figure 4: Formaldehyde metabolism in cultured neurons. A: Cells 
(circles) or cell-free wells (triangles) were incubated with 0.5 mM 
formaldehyde for up to 3 h and the concentration of formaldehyde and 
formate in the medium was determined. B: Rates of formaldehyde 
clearance and formate release as calculated from the slopes of the 
decrease and increase in extracellular formaldehyde and formate 
concentrations (A), respectively. C: Cellular content of formate in 
neurons that had been treated without or with 0.5 mM formaldehyde for 
2 h. D: Concentrations of disposed formaldehyde and released formate 
after a 2 h incubation of cells with 0.5 mM formaldehyde at 37?C or 4?C. 
In C and D the significance of differences (paired t-test) between the 
indicated conditions is indicated by #p<0.05 or ##p<0.01. n.d, not 
detectable. 
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Figure 5: Formaldehyde treatment enhances lactate release from 
cultured neurons. The cells were incubated without or with 0.5 mM 
formaldehyde for up to 3 h and the lactate content in the medium was 
measured (A). The rates of lactate release (B) was calculated from the 
slopes of the linear increases in extracellular lactate contents shown in 
panel A. The significance of differences (paired t-test) between the data 
obtained for cells incubated in the absence or presence of formaldehyde 
is indicated as ##p<0.01 or ###p<0.001. 
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Figure 6: Formaldehyde exposure accelerates GSH export from 
cultured neurons. The cells were incubated for up to 3 h (A-C) without 
or with formaldehyde in the concentrations indicated in panel A or for    
2 h (D-F) with formaldehyde in concentrations of up to 1 mM. The 
extracellular (A,D) and cellular (B,E) GSx contents were determined and 
the sum of GSx contents (C,F) was calculated for the respective 
conditions. The initial cellular GSx contents were 18.4 ± 1.8 (A-C) and 
20.5 ± 4.4 (D-F) nmol per mg. The significance of differences (ANOVA) 
compared to control (absence of formaldehyde) is indicated by 
***p<0.001.  
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Figure 7: Prevention of formaldehyde-stimulated GSH efflux by Mrp1 
inhibition.  Cultured neurons were treated without or with 0.5 mM 
formaldehyde in the absence or the presence of 50 µM MK571 for 2 h. 
The extracellular (A) and cellular (B) GSx and GSSG contents were 
measured after the incubation and the sum of GSx (C) was calculated for 
each condition. The initial cellular GSx content was 19.2 ± 3.2 nmol per 
mg. The significance of differences (ANOVA) compared to control (absence 
of formaldehyde and MK571) is indicated by ***p<0.001, while that 
between formaldehyde treatment in the presence or absence of MK571 
(paired t-test) is indicated by ###p<0.001. 
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Figure 8: Removal of formaldehyde abolishes the formaldehyde-
stimulated GSH efflux. Cultured neurons were pre-incubated for 1 h in 
the presence or absence of 0.5 mM formaldehyde. The pre-incubation 
medium was removed and cells were incubated with fresh medium 
containing no or 0.5 mM formaldehyde for further 2 h. Media samples 
were harvested at the indicated incubation periods and the extracellular 
GSx contents were determined. The GSH export rates (B) were calculated 
from the slopes of extracellular GSx accumulation during the main 
incubation (A). The initial cellular GSx content was 27.9 ± 2.9 nmol per 
mg. The significance of differences (ANOVA) compared to controls 
(absence of formaldehyde in pre- and main-incubation) is indicated by 
***p<0.001 while that between main incubation in the presence or 
absence of formaldehyde (paired t-test) is indicated by ##p<0.01. 
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Table 1: Primer sets and annealing temperatures used for reverse 
transcription PCRs. 
mRNA Primers Annealing 
temperature 
(?C) 
Amplicon 
size (bp) 
ADH1 5’-AGCCCATTCACCACTTCATC-3’ 
5’-GGCTGCTCCTGCTGTTTTAC-3’ 
 
60 248 
ADH3 5’-CAGCACGTTTTCCGAGTACA-3’ 
5’-GCCACTTTACAGCCCATGAT-3’ 
 
60 213 
ALDH2 5’-GACCTGGACAAGGCCAATTA-3’ 
5’-TCTTCTGTGGCACTTTGACG-3’ 
 
60 193 
ALDH1L1 5’-GTGCCGTGTTCAAGTTTCCT-3’ 
5’-CCATGAATGAGGGTCCAGTT-3’ 
 
60 226 
ALDH1L2 5’-CTCAGGGGTCTTCACGAGAG-3’ 
5’-CGAGGGTCACTGTTTTGGTT-3’ 
 
60 197 
MTHFD1 5’-CATGTGGTGGTTCTTGTTGC-3’ 
5’-AGGTCCAGCTCAGCATCTGT-3’ 
 
58 230 
MTHFD1L 5’-AATGTTTTGTTTCGCCCTTG-3’ 
5’-CACAATGTCTGCCTCTCGAA-3’ 
55 212 
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Discussion 
Cultured cerebellar granule neurons were used as a model system to investigate 
the consequences of a treatment of neurons with formaldehyde. Exposure of 
these cells to formaldehyde in concentrations of up to 1 mM was not acutely 
toxic. This resistance of cultured cerebellar granule neurons against toxicity of 
low concentrations of formaldehyde for short time-frames is consistent with 
literature data for cortical neurons (Song et al. 2010), PC12 cells (Lee et al. 
2008), astrocytes (Tulpule and Dringen 2011, Tulpule and Dringen 2012) and 
oligodendroglial OLN-93 cells (Tulpule et al. 2012). Cell viability of cerebellar 
granule neurons was only compromised during prolonged exposure of the cells 
to formaldehyde which may be caused by the observed alterations in cellular 
metabolism of formaldehyde-treated neurons and/or by the impairment of 
cellular functions due to its reactivity with cellular macromolecules (Lu et al. 
2010, Ospina et al. 2011). Animal experiments have revealed that formaldehyde 
causes neuronal damage by oxidative stress (Gurel et al. 2005, Zararsiz et al. 
2006, Zararsiz et al. 2007, Zararsiz et al. 2011). However, at least for viable 
neurons formaldehyde exposure did not increase the cellular or extracellular 
levels of GSSG, suggesting that cultured cerebellar granule neurons did not 
suffer from severe oxidative damage under the conditions used here.  
Rapid metabolism of formaldehyde can be excluded as potential reason for the 
relative resistance of cerebellar granule neurons against formaldehyde toxicity, 
as even after 3 h exposure still around 70% of the applied formaldehyde was 
detectable in the incubation medium. Nevertheless, cultured cerebellar granule 
neurons have the potential to metabolize formaldehyde and also consistently 
express the mRNAs for enzymes known to contribute to formaldehyde reduction 
to methanol (ADH1) and for formaldehyde oxidation to formate (ADH3 and 
ALDH2), confirming literature data on the expression of these enzymes in 
neurons in brain sections (Galter et al. 2003, Martinez et al. 2001, Su et al. 
2011). Also the mRNAs of the 10-formyl THF synthesizing enzymes, MTHFD1 
and MTHFD1L, were found in cultures of cerebellar granule neurons. While 
MTHFD1 has been previously shown to be expressed in neurons (Anthony and 
Heintz 2007), the presence of MTHFD1L has been demonstrated at least for 
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adult brain tissue (Prasannan et al. 2003). mRNA of ALDH1L2 was detected for 
cultured cerebellar granule neuron and astrocytes, which is consistent with the 
presence of this enzyme in the brain (Krupenko et al. 2010). However, only a 
marginal expression of ALDH1L1 mRNA was found for the neuron cultures as 
expected from the reported highly specific expression of ALDH1L1 in astrocytes 
(Cahoy et al. 2008). The very weak signal for ALDH1L1 mRNA observed for 
cerebellar granule neuron cultures may result from a few contaminating 
astrocytes in these cultures.  
Cultured cerebellar granule neurons are able to metabolize formaldehyde and 
cleared exogenous formaldehyde in a time- and temperature-dependent manner 
with a rate of about 200 nmol/(h x mg), which is similar to values recently 
reported for cultured astrocytes (Tulpule and Dringen 2012). Extracellular and 
cellular formate levels of formaldehyde-treated neurons accounted to 25% and 
10%, respectively, of the formaldehyde that had disappeared within 2 h from 
the medium, while no methanol generation from formaldehyde was observed 
(data not shown). The rather low rate of formate generation by cerebellar 
granule neurons contrasts the situation reported for astrocytes where 
formaldehyde is almost quantitatively oxidized to formate (Tulpule and Dringen 
2012). Evaporation of formaldehyde can be ruled out as the potential reason for 
the observed disappearance of formaldehyde as in the absence of neurons the 
decline in medium concentration of formaldehyde was only marginal. However, 
some interaction of formaldehyde with cellular macromolecules (Lu et al. 2010, 
Ospina et al. 2011) is likely to contribute to the observed loss of formaldehyde, 
since incubation of cells at 4?C prevented only half of the disappearance of 
formaldehyde, but completely prevented its oxidation to formate. In addition, 
since cultured neurons contain the mRNA for the enzymes responsible for 
formate oxidation, the complete enzymatic oxidation of some formaldehyde to 
CO2 is likely to also contribute to the observed cell-dependent loss of 
formaldehyde.  
Cultured cerebellar granule neurons produced lactate at a basal rate of around 
0.8 µmol/(h x mg) which is similar to the glycolytic rates previous reported for 
cultured neurons (Itoh et al. 2003, Zwingmann and Leibfritz 2003), but lower 
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than that reported for cultured astrocytes (about 1.3 µmol/(h x mg)) (Tulpule 
and Dringen 2012, Scheiber and Dringen 2011). This was expected since 
astrocytes are reported to be more glycolytic than neurons (Itoh et al. 2003, 
Zwingmann and Leibfritz 2003) possibly due to an inhibited pyruvate 
dehydrogenase complex (Halim et al. 2010) and a lower capacity for NADH 
shuttling into the mitochondria (Berkich et al. 2007, Neves et al. 2012). 
Exposure of neurons to formaldehyde rapidly increased lactate release and 
doubled their lactate release rate. This accelerated lactate release is likely to be 
a consequence of the accumulation of formaldehyde-derived formate in the cells 
which is a known inhibitor of cytochrome c oxidase (Wallace et al. 1997, 
Nicholls 1975), as inhibition of mitochondrial respiration has been reported to 
accelerate glycolytic lactate production in cultured neurons (Walz and Mukerji 
1988). A formaldehyde-induced stimulation of glycolytic flux has also been 
observed for cultured astrocytes (Tulpule and Dringen 2012). However, the 
onset of the increase in astrocytic lactate production was delayed by about one 
hour and the lactate release rate was only increased by up to 50% (Tulpule and 
Dringen 2012), while the extracellular lactate concentration in formaldehyde-
treated neuron cultures was already significantly elevated after 15 min and the 
lactate release rate was doubled compared to control neurons. These differences 
between cultured astrocytes and neurons in the modulation of glycolytic flux 
after formaldehyde application may be a consequence of the more efficient 
formate export from astrocytes (Tulpule and Dringen 2012) and the higher 
basal glycolytic flux rate in astrocytes (Bolanos et al. 2010).  
Cultured neurons release GSH only with a low specific rate, confirming 
literature data (Hirrlinger et al. 2002). However, application of formaldehyde 
strongly accelerated this basal GSH export in a concentration- and time-
dependent manner in a process that was completely prevented by the Mrp1-
inhibitor MK571, as recently also reported for cultured glial cells (Tulpule and 
Dringen 2011, Tulpule et al. 2012). Thus, formaldehyde-induced stimulation of 
Mrp1-mediated GSH export appears to be a common feature of neural cells. As 
formaldehyde application increases the Vmax-value of the GSH export from 
astrocytes 10-fold without changing the Km-value, a formaldehyde-induced 
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activation of Mrp1 and/or recruitment of additional transporters to the plasma 
membrane have been suggested as reasons for the accelerated GSH export 
(Tulpule et al. 2012). Such processes may also be involved in the accelerated 
Mrp1-mediated GSH export from formaldehyde-treated neurons. Furthermore, 
the observation that the formaldehyde-induced effect on Mrp1-mediated GSH 
transport is terminated by removing formaldehyde suggests that a rapidly 
reversible process is involved in the stimulated GSH export from neurons that 
requires the acute presence of formaldehyde.  
The concentrations of formaldehyde that were effective in stimulating glycolytic 
lactate production and GSH export and to generate formate in cultured neurons 
(present report) or cultured glial cells (Tulpule and Dringen 2012, Tulpule and 
Dringen 2011, Tulpule et al. 2012) are in the range of formaldehyde 
concentration that have been reported for blood (0.1 mM), brain cortex (0.4 mM) 
and hippocampus (0.2 mM) (Tong et al. 2012, Tong et al. 2011, Heck and 
Casanova 2004). Thus, the observed metabolic consequences of an exposure of 
brain cells to formaldehyde are likely to be relevant for the in vivo situation, 
especially under conditions that have been connected with elevated brain 
formaldehyde levels such as ageing, AD or multiple sclerosis (Tong et al. 2012, 
Tong et al. 2011, Khokhlov et al. 1989 cited in Miao and He 2012, Ferrer et al. 
2002, del Mar Hernandez et al. 2005, Unzeta et al. 2007, Airas et al. 2006).  
The observed formaldehyde-induced alterations in the metabolism of brain cells 
may severely compromise brain functions. Excess of formate generation has 
adverse effects on brain cells as extracellular formate is known to be neurotoxic 
(Kapur et al. 2007) and elevated cellular levels of formate will lower 
mitochondrial ATP production (Wallace et al. 1997). In addition, accelerated 
proton-coupled export of lactate and formate will result in metabolic acidosis 
which is known to compromise cell viability (Rose 2010, Yao and Haddad 2004). 
Furthermore, accumulation of extracellular GSH and depletion of neuronal GSH 
has been shown to cause excitotoxicity (Regan and Guo 1999b, Lee et al. 2010) 
and a combination of extracellular GSH accumulation with energy depletion 
further potentiates neuronal death (Regan and Guo 1999a). Finally, acidosis 
may even impair neuronal restoration of GSH as a lowered pH has been 
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reported to inhibit GSH synthesis (Lewerenz et al. 2010). Thus, elevated 
formaldehyde generation, formaldehyde-derived formate generation as well as 
formaldehyde-induced alterations in glucose and GSH metabolism in brain are 
likely to trigger a number of events that will synergistically compromise viability 
and functions of brain cells. These processes may contribute to the reported 
formaldehyde-induced oxidative damage, neurotoxicity and impaired cognitive 
potential (Songur et al. 2010, Tong et al. 2012, Tong et al. 2011).  
In summary, cerebellar granule neurons are capable of oxidizing formaldehyde 
and severely increase their lactate production and GSH release during exposure 
to formaldehyde. Such processes may contribute to the known neurotoxic 
potential of formaldehyde. Since ageing and disorders such as AD and multiple 
sclerosis have been connected both with elevated brain formaldehyde levels 
(Tong et al. 2012, Tong et al. 2011, Khokhlov et al. 1989 cited in Miao and He 
2012), and with oxidative damage and impaired energy metabolism (Leuner et 
al. 2012, Correia et al. 2012, Haider et al. 2011, Soler-Lopez et al. 2012, Sohal 
and Orr 2012), further studies are now required to investigate whether elevated 
brain formaldehyde levels as well as a potentially accelerated formate 
generation contribute to the disturbances observed in brain metabolism for 
these conditions.   
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4.1. Formaldehyde-induced neurotoxicity: comparison of exogenous 
and endogenous sources as risk factors 
 
Human exposure to formaldehyde can occur by inhalation, ingestion or entry 
through the skin (de Groot et al., 2009; Dhareshwar and Stella, 2008; NTP, 
2010). One pertinent question is whether exogenous formaldehyde can pose a 
big threat to the CNS by entering the blood and ultimately reaching the brain 
on crossing the BBB. Some studies have shown that formaldehyde inhalation 
does not substantially increase the level of formaldehyde in blood over the 
homeostatic value (Franks, 2005; Heck et al., 1985; Heck et al., 1982) and the 
brain (Heck et al., 1982). This is not surprising since the formaldehyde-
oxidizing enzymes ADH3 and ALDH2 are ubiquitously expressed in all tissues 
(Alnouti and Klaassen, 2008; Nishimura and Naito, 2006). Also, since the 
homeostatic concentration of formaldehyde in the blood is about 0.1 mM (Heck 
and Casanova, 2004; Heck et al., 1985), the body would have to be exposed to 
high doses of formaldehyde in order to exert cerebral damage after escaping its 
metabolism, predominantly in the liver. Indeed, exposure to formaldehyde has 
been reported to cause neurotoxicity in humans as well as animals and 
depends on the dose and duration of formaldehyde exposure (Kilburn et al., 
1985a; Kilburn et al., 1985b; Kilburn et al., 1989; Songur et al., 2010; Songur 
et al., 2008). Nevertheless, individuals carrying functional polymorphisms in 
the promoter of ADH3 or genetic polymorphisms in ALDH2 which are suggested 
to be associated with reduced formaldehyde-oxidizing capacity (Hedberg et al., 
2001; Wang et al., 2002) may be more vulnerable to neural damage by 
exogenous formaldehyde even at low doses.  
Under physiological conditions, the concentration of formaldehyde in brain 
(around 0.3 mM) (Tong et al., 2012) is higher than that in the blood (0.1 mM) 
(Heck and Casanova, 2004; Heck et al., 1985) which hints at a higher capacity 
of the brain to generate formaldehyde by endogenous processes. An elevation of 
such metabolic processes in diseases (Section 1.1.4) has the potential to expose 
this organ to considerably high levels of formaldehyde as observed in AD, as 
well as diabetes (Tong et al., 2012; Tong et al., 2011). Thus, the risk of 
neurotoxicity from an increase in formaldehyde generated within the brain 
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tissue seems higher compared to exposure to exogenous formaldehyde which 
may enter the brain after escaping peripheral metabolism. 
 
 
4.2. Effects of formaldehyde application on brain cells 
Since the brain encounters formaldehyde in physiological conditions and the 
level of exposure increases in pathological conditions (Tong et al., 2012; Tong et 
al., 2011), the ability of brain cells to metabolize formaldehyde was investigated 
in this thesis. Astrocyte-rich primary cultures, cerebellar granule neurons 
cultures as well as the oligodendroglial cell-line OLN-93 were employed as 
model systems for astrocytes, neurons and oligodendrocytes, respectively 
(Drejer et al., 2008; Lange et al., 2012; Richter-Landsberg and Heinrich, 1996). 
The advantage of these cultures is that they enable studies on a specific brain 
cell-type with minimal interference from other cells which constitute the brain. 
Formaldehyde oxidation generates formate, a mitochondrial respiration 
inhibitor (Nicholls, 1975; Wallace et al., 1997) while the pathway of 
formaldehyde oxidation involves GSH (Friedenson, 2011; MacAllister et al., 
2011), an important antioxidant (Lushchak, 2012; Schmidt and Dringen, 2012). 
Therefore, it was interesting to test for the consequence of a formaldehyde 
treatment on the glucose and GSH metabolism of these cells.  
The presence of mRNAs for the enzymes involved in formaldehyde generation 
and disposal (Sections 1.1.2 and 1.1.3) was analyzed qualitatively in these 
cultures using reverse transcription (RT)-PCR (Fig. 4.1). All cultures contained 
the mRNA of SSAO and LSD1 (formaldehyde-generating enzymes) as well as for 
ADH3 and ALDH2 (formaldehyde-oxidizing enzymes) which verifies previous 
reports on the expression of these enzymes in the brain (Table 1.3). 
Furthermore, the mRNA of ADH1 (formaldehyde-reducing enzyme) was also 
expressed in all the cultures which is in agreement with a previous study 
(Martinez et al., 2001). Amongst the enzymes involved in THF-dependent 
formate oxidation, MTHFD1 and MTHFD1L which have been shown to be 
expressed in the brain (Anthony and Heintz, 2007; MacFarlane et al., 2009; 
Prasannan et al., 2003) were also expressed in all the cultures. On the contrary, 
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mRNA of the 10-formyl THF-oxidizing enzyme, ALDH1L1 was hardly detectable 
in cultured neurons and OLN-93 cells which is not surprising since ALDH1L1 is 
considered to be an astrocyte-specific protein (Cahoy et al., 2008). Furthermore, 
the mRNA of ALDH1L2 which has been reported to be present in the total brain 
tissue (Krupenko et al., 2010), was present in all cultures except OLN-93 cells. 
Thus, all types of brain cell cultures used in this study may possess the 
capacity to generate and dispose formaldehyde. 
 
Figure 4.1: RT-PCR analysis of the formaldehyde-generating and                     
-metabolizing enzymes in cultured brain cells.  
4.2.1. Formaldehyde metabolism 
The concentrations of formaldehyde used for exposure of cultures were in the 
(patho)physiologically relevant range (Heck and Casanova, 2004; Heck et al., 
1985; Tong et al., 2012; Tong et al., 2011). Cultured astrocytes, OLN-93 cells as 
well as cultured cerebellar granule neurons withstood formaldehyde application 
in concentrations of up to 1 mM for up to 4 h (Chapters 3.1-3.4) which is in line 
with the reported resistance of cultured brain cells to formaldehyde toxicity for 
a time-frame of a few hours (Song et al., 2010; Tong et al., 2012). On the 
contrary, exposure of microglial cultures to formaldehyde resulted in an almost 
complete cell death, assessed by LDH release, within 30 min of incubation (data 
not shown). The resistance of cultured brain cells to formaldehyde toxicity could 
be due to their ability to metabolize the applied formaldehyde, since this 
compound is more cytotoxic than its metabolites, methanol and formate (Lee et 
al., 2008; Oyama et al., 2002). 
 
 
 
 
 
Table 4.1: Metabolism of formaldehyde and consequences of formaldehyde exposure on the glucose and 
glutathione metabolism in cultured brain cells#.  
 
#The data on formaldehyde metabolism and its impact on glucose metabolism in OLN-93 cells are from Tongaonkar (2012). 
The data on glutathione export rate from OLN-93 cells in the presence of 1 mM formaldehyde are from Boecker (2011). All 
other data sets are compiled from Chapters 3.1-3.4. Significance of differences compared to cultured astrocytes (ANOVA or 
unpaired t-test) is indicated by *p<0.05, **p<0.01 and **p<0.001. For one culture type, significance of differences compared to 
the control condition (ANOVA or t-test) is indicated by §p<0.05, §§p<0.05 and §§§p<0.001. n.a, not applicable (unpaired data); 
n.d, not determined.  
     
Parameter  [HCHO] 
(mM) 
APC  
n 
      OLN-93   
n 
       CGNC  
n 
Protein content (µg/well)  113 ± 18 32 76 ± 6*** 22 51 ± 10*** 20 
 
Formaldehyde metabolism 
Formaldehyde clearance 
rate (nmol/(h x mg)) 
0.5 299 ± 27 3               n.d   321 ± 120 8 
1 322 ± 110 6 244 ± 39 3               n.d  
 
Formate release rate 
(nmol/(h x mg)) 
0.5 299 ± 34 3               n.d  51 ± 7*** 7 
1 276 ± 89 6 188 ± 8 3               n.d  
 
Formaldehyde clearance 
to formate release ratio 
 
0.5 1.0 ± 0.0 3               n.d            n.a  
1 0.9 ± 0.1 6 0.8 ± 0.1 3       n.d  
 
Glucose metabolism 
Lactate release rate  
(µmol/(h x mg)) 
 
 
0 1.4 ± 0.2 18 1.0 ± 0.1*** 10 0.9 ± 0.2*** 5 
0.5 1.3 ± 0.1 3 1.6 ± 0.1§§§ 3 1.6 ± 0.3§§ 5 
1 2.0 ± 0.2§§§ 18 1.8 ± 0.2§§§ 10             n.d  
 
Glucose consumption 
rate (µmol/(h x mg)) 
 
 
0 0.7 ± 0.1 6 0.4 ± 0.1*** 10             n.d  
0.5 0.6 ± 0.1 6 0.6 ± 0.0§ 3             n.d  
1 1.0 ± 0.1§§§ 6 0.7 ± 0.1***,§§§ 10             n.d  
 
Lactate release to glucose 
consumption ratio 
 
 
0 1.8 ± 0.4 6 2.5 ± 0.6* 10             n.d  
0.5 2.3 ± 0.4 6 2.6 ± 0.3 3             n.d  
1 1.9 ± 0.4 6 2.4 ± 0.4* 10             n.d  
 
Glutathione export 
Cellular GSH content 
(nmol/mg) 
 
 51.5 ± 12.4 19 43.8 ± 4.4*** 22 20.6 ± 4.8*** 15 
 
GSH export rate  
(nmol/(h x mg)) 
 
 
0 1.5 ± 0.3 13 0.4 ± 0.3** 14 1.1 ± 0.5* 6 
0.5 20.3 ± 2.8§§§ 3 10.7 ± 1.2***,§§§ 14 4.7 ± 1.3***,§§§ 6 
1 18.2 ± 2.5§§§ 13 11.8 ± 2.6***,§§§ 3 5.2 ± 0.9***,§§§ 3 
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All types of cultures used in this study have the potential to clear the applied 
formaldehyde at a rate of about 0.3 µmol/(h x mg) (Table 1.4) which is similar to 
the formaldehyde oxidation rate of brain cortex homogenate (around 0.2 
µmol/(h x mg)) (Iborra et al., 1992), but is only a fifth of the oxidation rate 
found for liver cells (Dicker and Cederbaum, 1984). The Km-value for 
formaldehyde clearance in cultured astrocytes was calculated to be around 0.19 
mM (Chapter 3.1). Since the Km-value of ADH3 (for S-hydroxymethyl GSH) and 
ALDH2 (for formaldehyde) is less than 10 µM and around 0.2-0.5 mM, 
respectively, (Casanova-Schmitz et al., 1984; Heck et al., 1990), under the 
conditions used, both the cytosolic ADH3 and mitochondrial ALDH2 are likely 
to contribute to formaldehyde oxidation. 
The difference between the various brain cell cultures lies in the fate of the 
formaldehyde metabolized. While in astrocytes and OLN-93 cells, majority of the 
formate that was generated by formaldehyde oxidation was exported into the 
medium, in neurons only about 25% of the cleared formaldehyde was detectable 
as extracellular formate (Table 4.1). The reason behind these differences might 
be that cultured neurons export formate poorly and/or are better equipped with 
enzymes responsible for further oxidation of formate to carbon dioxide (Fig. 1.5). 
The putative exporters for formate are GABA receptors (Mason et al., 1990) and 
monocarboxylate transporter (MCT) 1 (Moschen et al., 2012), both of which are 
expressed in astrocytes (Debernardi et al., 2003; Lee et al., 2011; Velez-Fort et 
al., 2011), oligodendrocytes (Luyt et al., 2007) and neurons (Debernardi et al., 
2003; Olsen and Sieghart, 2009; Rinholm et al., 2011). However, unlike other 
brain cells, the expression level of MCT1 in neurons has been reported to be 
very low (Debernardi et al., 2003). If poor export of formate would be the only 
reason behind the observation that in neurons only 25% of the disappearing 
formaldehyde was found as extracellular formate (Chapter 3.4), the remaining 
75% of the formaldehyde-derived formate should be detected within cells. 
Indeed, the amount of formate that accumulated in neurons on treatment with 
0.5 mM formaldehyde for 2 h was about three-fold higher than that in cultured 
astrocytes on application of the same concentration of formaldehyde for 3 h 
(Table 4.2). However, this formate accounted for only 10% of the formaldehyde 
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that had disappeared from the medium (Chapter 3.4). Thus, the lower 
extracellular accumulation of formate in cerebellar granule neurons compared 
to cultured astrocytes and OLN-93 cells may be due to a combination of poor 
export and further oxidation of the cellular formate to carbon dioxide.  
 
 
Table 4.2: Cellular accumulation of formaldehyde-derived formate in 
cultured brain cells. 
Culture  Incubation 
conditions 
Cellular formate  
content 
n Reference 
 [HCHO] 
(mM) 
Time 
(h) 
(nmol/mg)   
 
APC 0.5 
1 
3 
3 
 5.2 
13.6 
± 
± 
0.9 
2.2 
3 
3 
Chapter 3.1 
Chapter 3.1 
 
 
OLN-93 1 5 22.2 ± 6.6 3 Tongaonkar, 2012 
CGNC 0.5 2 14.7 ± 5.0 4 Chapter 3.4 
 
 
 
4.2.2. Formaldehyde-stimulated lactate release 
All the neural cell cultures used here oxidized the applied formaldehyde to 
formate leading to an elevated cellular level of formate (Chapters 3.1, 3.4; 
Tongaonkar, 2012). The formate present in the cells can potentially inhibit 
mitochondrial cytochrome c oxidase (Nicholls, 1975; Wallace et al., 1997) and 
alter the glucose metabolism of formaldehyde-treated cultures. Therefore, 
glucose consumption and lactate release of formaldehyde-treated cells was 
investigated. The basal rates of lactate release and glucose consumption in 
cultured astrocytes (Table 4.1) were similar to previous reports (Fonseca et al., 
2005; Scheiber and Dringen, 2011) and the ratio of these rates was around 2 
indicating that these cells are highly glycolytic. This feature of astrocytes has 
been attributed to the inhibition of pyruvate dehydrogenase complex (Halim et 
al., 2010) and a low NADH shuttling into the mitochondria (Berkich et al., 
2007; Neves et al., 2012). Like astrocytes, OLN-93 cells are also glycolytic as 
evident from the high ratio of lactate release to glucose consumption, although 
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the respective rates are significantly lower compared to astrocytes (Table 4.1). 
While the glucose consumption in cultured neurons could not be measured 
reliably, the lactate release rate from these cultures is comparable to literature 
data (Itoh et al., 2003; Pauwels et al., 1985; Walz and Mukerji, 1988; 
Zwingmann and Leibfritz, 2003) and was significantly lower than that of 
cultured astrocytes (Table 4.1). This was expected, since astrocytes are reported 
to be more glycolytic compared to neurons (Walz and Mukerji, 1988; 
Zwingmann and Leibfritz, 2003). The release of lactate by astrocytes is 
considered highly important to support neuronal energy demand (Fernandez-
Fernandez et al., 2012; Pellerin and Magistretti, 2012) and oligodendrocyte 
development and myelination (Rinholm et al., 2011), while lactate release from 
oligodendrocytes is suggested to provide energy substrate to myelinated 
neurons (Fünfschilling et al., 2012; Lee et al., 2012).  
Formaldehyde exposure elevated lactate release from all types of brain cell 
cultures (Table 4.1). However, the extent of the increase in lactate release rate 
over basal rate differed between the culture types (Table 4.1). While at a 
formaldehyde concentration of 0.5 mM, the lactate release rate increased by 
about 60% and 100% in OLN-93 cells and cultured neurons, respectively, the 
rate was unaltered in cultured astrocytes. On the other hand, an application of 
1 mM formaldehyde was required to increase glycolysis by about 50% in 
cultured astrocytes. Furthermore, in cultured astrocytes, the lactate release 
rate remained high compared to the basal rate even on removal of formaldehyde 
after 1 h of incubation and this persistent lactate release was not further 
enhanced by application of azide, another inhibitor of mitochondrial cytochrome 
c oxidase (Chapter 3.1). These observations strengthen the hypothesis that the 
effect of elevated glycolytic flux is not due to formaldehyde itself but due to 
formate.  Thus, the differences in the extent of acceleration of lactate release on 
formaldehyde treatment of cultured astrocytes, OLN-93 cells and neurons may 
depend, at least partly, on the cellular concentrations of formate achieved to 
inhibit mitochondrial respiration. For example, in cultures the cell volume of 
human astrocytes is estimated to be ten times that of neurons (Zhang et al., 
2002). Therefore, in astrocytes, substantially higher amounts of cellular formate 
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would be required to attain the same concentration of formate like that in 
neurons for mitochondrial inhibition.  
 
 
4.2.3. Formaldehyde-accelerated glutathione deprivation 
For all types of neuronal cultures, oxidized glutathione (GSSG) contributed only 
marginally to the amounts of total glutathione (GSx) measured both in cells and 
media (Chapters 3.2-3.4) indicating that most of the GSx was GSH. The initial 
cellular GSH content as well as the basal GSH export was the highest in 
astrocytes compared to other cultures which is in line with a previous report 
(Hirrlinger et al., 2002). Around 60% of the basal GSH export from astrocytes is 
mediated by Mrp1 (Minich et al., 2006), a member of ATP-binding cassette 
transporters (Keppler, 2011). Besides GSH, Mrp1 transports a wide array of 
substrates, including GSSG as well as GSH conjugates (Keppler, 2011). 
However, this transporter differs in its Km-value for the different substrates. 
The Km-value of Mrp1 for GSH is above 5 mM, while that for GSSG and GSH 
conjugates is about 100 µM and less than 1 mM, respectively (Cole and Deeley, 
2006; Deeley and Cole, 2006; Leier et al., 1996).  
 
Table 4.3: Duration of incubation and concentration of 
formaldehyde required for half-maximal GSH export from cultured 
brain cells.  
 
  
 
 
Formaldehyde treatment increased Mrp1-mediated GSH export from all types of 
cultured brain cells investigated (Chapters 3.2-3.4). The concentration of 
formaldehyde and the duration of incubation required for half-maximal GSH 
Culture  [HCHO]  
(mM) 
Time  
(h) 
Reference 
    
APC 0.3 1 Chapter 3.2 
OLN-93 0.2 0.75 Chapter 3.3 
CGNC 0.3 1 Chapter 3.4 
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export were similar for the different culture types (Table 4.3). The stimulated 
GSH efflux observed in the presence of formaldehyde was hypothesized to be 
due to the Mrp1-mediated export of either GSH or of the formaldehyde-GSH 
conjugate, S-hydroxymethyl GSH (Fig. 4.2). The latter is known to be labile 
(Ahmed and Anders, 1978) and is likely to disintegrate into formaldehyde and 
GSH immediately after its export due to the change in the equilibrium between 
the reactants and the product. 
 
 
Figure 4.2: Hypothesized mechanism behind formaldehyde-
stimulated GSH export. Formaldehyde may directly stimulate Mrp1-
mediated GSH export (A). Alternatively, formaldehyde may react with 
GSH in cells to form S-hydroxymethyl GSH which is exported by Mrp1 
and immediately disintegrates into formaldehyde and GSH on its release 
into the medium due to the labile nature of this conjugate (B). 
 
To obtain a better insight into the identity of the GSH moiety exported in the 
presence of formaldehyde, the kinetic parameters for basal and formaldehyde-
stimulated GSH export were determined, since Mrp1 has different Km-values 
for GSH and its conjugates (Cole and Deeley, 2006; Deeley and Cole, 2006). The 
Km- and Vmax-value for the basal GSH export in cultured astrocytes was about 
100 nmol/mg (about 25 mM) and 4 nmol/(h x mg), respectively (Chapter 3.3) 
which was comparable to literature data (Sagara et al., 1996). On application of 
formaldehyde to cultured astrocytes, the Km-value for formaldehyde-stimulated 
GSH export was identical to that for the basal GSH export, while the Vmax-
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value increased by a factor of 10 (Chapter 3.3). This indicates that GSH rather 
than S-hydroxymethyl GSH is exported by Mrp1 in the presence of 
formaldehyde, since an export of S-hydroxymethyl GSH should lead to a 
lowering of the Km-value for GSH export, owing to the lower Km-value of Mrp1 
for GSH conjugates (Cole and Deeley, 2006; Deeley and Cole, 2006). Although 
the kinetic parameters for the basal GSH export in OLN-93 cells and that for 
basal as well as stimulated GSH export in cultured neurons could not be 
determined, it is likely that in the presence of formaldehyde, GSH rather than 
the conjugate is exported from both types of cultures. 
Since the stimulation of GSH export was observed within minutes after 
formaldehyde application (Chapters 3.2-3.4), de novo synthesis of Mrp1 seems 
unlikely to explain the stimulated GSH efflux. Furthermore, the observation 
that removal of formaldehyde instantly decelerates the stimulated GSH export 
(Chapters 3.2-3.4) indicates that the formaldehyde-accelerated GSH export is 
reversible. The molecular mechanism behind the accelerated GSH export in the 
presence of formaldehyde could be either recruitment of Mrp1 to the cell 
membrane and/or covalent activation of this transporter. Although no evidence 
for activation of Mrp1 is found in literature, a reversible translocation of Mrp1 
from the Golgi apparatus to the cell surface has at least been reported for 
cultured astrocytes treated with bilirubin (Gennuso et al., 2004).  
The amount of GSSG detected in cells and media on formaldehyde treatment for 
all the cultures used was marginal (Chapters 3.2-3.4). This indicates that the 
cells did not encounter severe formaldehyde-induced oxidative stress under the 
conditions used, although this aldehyde is known to induce oxidative stress in 
the brain (Songur et al., 2008; Zararsiz et al., 2006; Zararsiz et al., 2007; 
Zararsiz et al., 2011). The lack of severe oxidative stress observed in the 
cultures on exposure to formaldehyde could be due to a reinforced antioxidative 
capacity of brain cells in cultures compared to the respective cells in vivo. 
Nevertheless, studies on formaldehyde-induced oxidative damage in vitro used 
lower doses of formaldehyde for longer time-frames than those used in the 
current study (Song et al., 2010; Tang et al., 2011; Zhang et al., 2010). Hence it 
is likely that exposure to formaldehyde for a short duration does not induce 
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oxidative damage but that oxidative stress is rather a consequence of a chronic 
exposure.  
Application of formaldehyde does not deprive the cells completely of their GSH 
and about 5% residual GSH still remains within cells (Chapters 3.2-3.4). The 
cellular concentration of the remaining GSH is sufficiently high (astrocytes have 
a cell volume of 4.1 µL/mg (Dringen and Hamprecht, 1998)) to drive ADH3-
catalyzed GSH-dependent formaldehyde oxidation, since the Km-value of ADH3 
for S-hydroxymethyl GSH is less than 10 µM (Casanova-Schmitz et al., 1984; 
Heck et al., 1990) and this reaction involves recycling of GSH (Fig. 4.3). Thus, 
the stimulated GSH export will not hamper the GSH-dependent formaldehyde 
oxidation. 
Fig. 4.3 shows the current scheme on the metabolism of formaldehyde in brain 
cells and on consequences of such an exposure on the glucose and glutathione 
metabolism based on the data described in this thesis. Formaldehyde 
application to cultured brain cells results in oxidation of formaldehyde to 
generate formate which most likely inhibits complex IV of the mitochondrial 
respiratory chain (Nicholls, 1975; Wallace et al., 1997), thereby increasing the 
glycolytic flux. On the other hand, formaldehyde deprives cultured brain cells of 
GSH by stimulating Mrp1-mediated GSH export. 
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Figure 4.3: Formaldehyde oxidation by cultured brain cells and the 
acceleration of glycolytic flux and GSH export on formaldehyde 
exposure. Exogenously applied formaldehyde is oxidized to formate in a 
pathway mediated by cytosolic ADH3 in a GSH-dependent process or by 
the mitochondrial ALDH2. At least a part of the formate generated within 
cells is exported while a fraction may be further oxidized to carbon 
dioxide. Remaining cellular formate is likely to inhibit mitochondrial 
complex IV which in turn accelerates glycolysis resulting in elevated 
lactate release. Formaldehyde also induces a rapid GSH export in a 
process mediated by Mrp1. Red arrows indicate the metabolic processes 
stimulated on formaldehyde exposure.    
 
 
4.3. (Patho)physiological implications  
The present study gives a novel insight into the metabolism of formaldehyde by 
brain cells and on the alterations in the glucose and GSH metabolism on 
exposure of cells to formaldehyde using in vitro model systems. However, the 
extrapolation of the results obtained in this thesis to the situation in vivo when 
the brain encounters high levels of formaldehyde should be done with caution 
due to the limitations of these model systems (De Vries and Boullerne, 2010; 
Gibbons and Dragunow, 2010; Lange et al., 2012). Furthermore, it should also 
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be considered that despite the use of physiologically relevant concentrations in 
this study, the amount of formaldehyde that brain cells encounter in vivo would 
be far less than that in vitro due to the low (about 20%) volume fraction (ratio of 
volume of extracellular matrix to that of the tissue) in vivo (Nicholson, 2001; 
Sykova and Nicholson, 2008). This could also be an explanation for the increase 
in lactate and GSH efflux seen on treatment of cultured brain cells with 
concentrations of formaldehyde that are reported in the healthy brain (Tong et 
al., 2012), although such a situation in vivo may pose a severe threat to this 
organ. Nevertheless, when the formaldehyde concentration in the brain rises 
over the homeostatic value alterations in brain energy and GSH metabolism are 
likely to occur.  
On exposure of brain to high concentrations of formaldehyde, astrocytes, 
oligodendrocytes and neurons may oxidize this aldehyde as has been reported 
for brain homogenates (Iborra et al., 1992). Subsequently, formate and lactate 
may be released from the cells (Fig. 4.3). Although the release of lactate by 
astrocytes and oligodendrocytes is considered to be neuroprotective 
(Fünfschilling et al., 2012; Lee et al., 2012; Pellerin and Magistretti, 2012), a 
formate-induced inhibition of mitochondrial cytochrome c oxidase in neurons 
would slow down oxidative ATP generation through the TCA cycle (Fig. 1.7). An 
up-regulation of glycolysis by brain cells may serve as a transient solution to 
meet their energy demands, however on prolonged exposure to formaldehyde 
the cells will suffer from an energy crisis that in turn will disrupt their 
functions. For example, oligodendrocytes have a high energy requirement for 
myelination (Harris and Attwell, 2012), hence disturbed energy metabolism of 
these cells on exposure to high levels of formaldehyde may affect the 
myelination of axons which is crucial for learning and cognition (Fields, 2008; 
Huang et al., 2009). Besides impairment of energy metabolism, formaldehyde-
induced generation of both formic acid and lactic acid in the brain can lead to 
cerebral acidosis (Rose, 2010; Skrzydlewska, 2003; Yao and Haddad, 2004). 
Lactic acidosis results in swelling of astrocytes, impairment of signal 
transmission in neurons and neurological deficits (Li et al., 2011; Staub et al., 
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1993; Zhao et al., 2011). In addition, formic acid has been shown to exert 
neurotoxicity in hippocampal brain slices (Kapur et al., 2007). 
Exposure of brain cells to high levels of formaldehyde will cause a depletion of 
GSH in these cells and GSH accumulation in the extracellular space. As GSH 
has important cellular functions in the brain such as protection against reactive 
oxygen species and detoxification of xenobiotics (Schmidt and Dringen, 2012), 
GSH deprivation of cells by prolonged exposure to formaldehyde may cause 
severe oxidative stress as previously reported (Songur et al., 2008; Zararsiz et 
al., 2006; Zararsiz et al., 2007; Zararsiz et al., 2011), unless the capacity of 
cells to synthesize GSH is up-regulated sufficiently to compensate for this loss. 
However, acidosis, which is likely to be a manifestation of formaldehyde 
exposure due to production of formic acid and lactic acid (Rose, 2010; 
Skrzydlewska, 2003), has been shown to slow down GSH synthesis (Lewerenz et 
al., 2010). This may render the cells incapable of fully restoring their GSH 
levels.  
The formaldehyde-induced accumulation of extracellular GSH in brain may also 
be detrimental since GSH has been suggested to act as a neurotransmitter and 
neuromodulator at glutamate receptors (Janáky et al., 2007) which play 
important roles in memory and learning (Davis et al., 2012; Mukherjee and 
Manahan-Vaughan, 2012). Likewise, GSH breakdown by the astrocytic 
??????????? ?-GT (Fig. 1.7) generates the neurotransmitter, glutamate 
(Fernandez-Fernandez et al., 2012; Schmidt and Dringen, 2012). Thus, 
excessive accumulation of extracellular GSH, its oxidation product GSSG as 
well as GSH-derived glutamate can cause excitotoxicty which has at least been 
demonstrated in vitro (Regan and Guo, 1999a; Regan and Guo, 1999b).  
Conditions such as ageing and diseases like MS and AD which are associated 
with increased levels of formaldehyde in brain (Khokhlov et al., 1989; Miao and 
He, 2012; Tong et al., 2012; Tong et al., 2011) have been connected to impaired 
mitochondrial function (Boumezbeur et al., 2010; Leuner et al., 2012; Mahad et 
al., 2008; Sullivan and Brown, 2005) along with an increase in brain lactate 
content (Paling et al., 2011; Parnetti et al., 2000; Ross et al., 2010). Also, 
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oxidative stress in the brain has been connected with ageing, MS and AD 
(Belkacemi and Ramassamy, 2012; Haider et al., 2011; Sohal and Orr, 2012; 
Steele and Robinson, 2012; van Horssen et al., 2011). These reports strengthen 
the view that formaldehyde may, at least to some extent, have a causal role in 
the initiation and/or progression of pathological symptoms of 
neurodegenerative conditions (Monte, 2010; Yu, 2001). An adequate supply of 
lactate to neurons has been shown to modulate memory formation (Suzuki et 
al., 2011) while GSH depletion in the brain has been demonstrated to result in 
behavioral changes (Steullet et al., 2010). Thus, the formaldehyde-induced 
alterations in glucose and GSH metabolism may contribute to the deficits in 
behavior, cognition and learning observed in animals after exposure to 
formaldehyde (Lu et al., 2008; Malek et al., 2003; Pitten et al., 2000; Tong et al., 
2012; Tong et al., 2011) or in neurodegenerative conditions such as AD 
(Stopford et al., 2012).  
 
 
4.4. Future perspectives  
This thesis throws light on the capacity of cultured brain cells to clear 
exogenously applied formaldehyde and also the consequences of formaldehyde 
exposure on the energy and GSH metabolism of brain cells. Based on the 
experimental evidence presented in this thesis some aspects still need to be 
addressed to complete the scheme (Fig. 4.3) and to understand better the 
underlying mechanisms. 
The expression of the enzymes involved in formaldehyde generation and 
metabolism should be ascertained on the protein level using Western blot 
analysis as well as immunocytochemistry. Also, the metabolism of 
formaldehyde to carbon dioxide, especially in neurons, remains to be verified. 
RNA interference technology (Siomi and Siomi, 2009) can be used to silence the 
genes of the enzymes involved in the metabolism of this aldehyde and 
formaldehyde oxidation can be assessed using the biochemical tools used in 
this thesis. As an alternative, these enzymes can also be inhibited using known 
chemical inhibitors. For example, ALDH2 can be inhibited by daidizin, 
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crotonaldehyde, chloral hydrate or disulfiram (MacAllister et al., 2011; Teng et 
al., 2001; Tong et al., 2012). Such studies would give a better insight into the 
contribution of different enzymes involved in the metabolism of formaldehyde in 
brain cells. Furthermore, a direct evidence for the inhibition of mitochondrial 
complex IV in cultured brain cells on formaldehyde treatment can be obtained 
by measuring the activity of this complex using a previously described method 
(Wharton and Tzagoloff, 1967). 
The putative transporters responsible for the export of formate are GABA 
receptors and MCT1 (Mason et al., 1990; Moschen et al., 2012). However, the 
role of these transporters in the efflux of formaldehyde-derived formate from the 
cultures used in this study was not assessed. The involvement of GABA 
receptors can be investigated using zinc ions which inhibit the receptor (Hosie 
et al., 2003) while AR-C117977, a highly specific inhibitor of MCT1 (Ekberg et 
al., 2007) can be employed to test for its involvement. In order to evaluate the 
hypothesis that formaldehyde-stimulated GSH export involves trafficking of 
Mrp1 to the cell surface from the Golgi apparatus, immunofluorescence staining 
of this protein can be performed to investigate its localization before and after 
formaldehyde treatment by confocal microscopy.  
Studies on formaldehyde exposure of microglial cultures could be performed to 
investigate the mechanism behind the unexpected vulnerability of these cells to 
formaldehyde. Such an investigation may provide an interesting insight into a 
potential selective vulnerability of microglia in vivo in conditions associated with 
elevated brain formaldehyde levels.   
Formaldehyde has been hypothesized to be involved in the pathology of 
neurodegenerative diseases (Monte, 2010; Yu, 2001). However, the literature 
evidence for an increase in brain formaldehyde levels in neurodegeneration is 
limited. Also, such reports (Tong et al., 2011; Tong et al., 2012) are not verified 
by independent studies. Therefore, the level of formaldehyde in post-mortem 
brains of patients as well as animal models for the conditions associated with 
an increase in formaldehyde-generating enzymes should be determined. Besides 
brain, urine formaldehyde levels may also be of interest since cognitive deficits 
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post-operation or in senile dementia correlate with urine formaldehyde levels 
and have been suggested to be prognostic markers for these conditions (Tong et 
al., 2011; Wang et al., 2012). The radiometric Dimedone-14C method (Szarvas et 
al., 1986) or high performance liquid chromatography with a fluorescence 
detector (Luo et al., 2001) can be employed to determine formaldehyde levels in 
biological samples. Such studies may help in establishing a stronger link 
between formaldehyde and neurodegeneration.  
Microdialysis is a widely used technique in neuroscience that facilitates 
sampling and collection of low molecular weight compounds from the 
extracellular space in the brain of humans as well as animals (Chefer et al., 
2009). This valuable tool should be employed for determination of metabolites 
such as formate, lactate and GSH in healthy and the diseased brains for 
conditions associated with an increase in brain formaldehyde level. Comparison 
of the extracellular levels of these metabolites in the brain and correlating them 
to the levels of formaldehyde observed in (patho)physiology would help to 
validate the results obtained in cultured brain cells for the situation in vivo.     
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